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CHAPTER 1 
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1.3 References 
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General Introduction and alms of the study 
1.1 RELATIONSHIP BETWEEN NOCTURNAL SATURATION AND 
RESPIRATORY MUSCLE STRENGTH 
Chronic obstructive pulmonary disease (COPD) is defined as a disorder 
characterized by abnormal tests of expiratory flow which do not change 
markedly over periods of several months of observation1 The three disorders 
which are incorporated in COPD are emphysema, peripheral airways disease 
and chronic obstructive bronchitis 
Patients with severe COPD run a high risk of desaturatmg during the night2"4 
The most important mechanism is hypoventilation5, which is mainly associated 
with rapid eye movement (REM) sleep During this stage there is a considerable 
loss of skeletal postural muscle tone and a decreased activity of intercostal 
and accessory respiratory muscles 6 9 This appears to be caused by supraspi-
nal inhibition of gamma motorneurons, and presynaptic inhibition of afferent 
terminals from muscle spindles The diaphragm is driven almost exclusively by 
alpha motorneurons It has considerable fewer muscle spindles than intercos-
tal muscles and has little tonic (postural) activity10 Therefore, the diaphragm 
escapes from reduction of activation during REM sleep However, in patients 
with COPD, strength and endurance of the diaphragm are affected by its 
unfavourable position on the length-tension curve due to hyperinflation 11 and 
it may not be able to compensate for the decreased activities of the other 
respiratory muscles For this reason we hypothesized that desaturations will 
occur in patients with low inspiratory muscle strength and especially in patients 
with lower maximal inspiratory transdiaphragmatic pressures This could have 
therapeutic consequences, since inspiratory muscle training can improve 
inspiratory muscle strength and endurance 12 14 and as a consequence, 
possibly also the nocturnal saturation in these patients 
1.2 AIMS OF THE STUDY 
Measurement of maximal respiratory pressures is an accepted method of 
evaluating respiratory muscle strength The pressure measurements, however, 
are influenced by factors related to the measurement itself and by factors 
related to COPD 
The aim of chapter 3 was to study measurement-related factors such as 
differences between static and dynamic maximal inspiratory mouth pressures, 
the effects of body position on these pressures, the influence of nasal patency 
on dynamic maximal sniff inspiratory pressures and the potential occurrence 
of fatigue during dynamic maximal sniff inspiratory pressures in 40 healthy 
subjects Conventionally, these pressures are measured in the upright posi-
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tion However, this position is not representative of the sleeping situation 
Therefore the effects of body position on maximal respiratory pressures were 
studied in chapters 3 and 4 
The aim of chapter 4 was to study the influence of body position, hyperinflation 
and blood gas tensions on maximal inspiratory pressures in 30 male patients 
with COPD. Theoretically it seems possible to increase the length of the 
diaphragm in patients with COPD by changing position from sitting to supine 
This has already been proven for the canine diaphragm15 In contrast to healthy 
subjects, the increased diaphragm length in supine position might result in 
higher transdiaphragmatic pressures in this position than in sitting position 
The aim of chapter 5 was to study the relationship between nocturnal saturation 
and respiratory muscle function in 34 patients with a wide range of severity of 
COPD Lung function and blood gas tensions were also assessed as co-vari-
ables 
During an exacerbation blood gas tensions and nocturnal saturation deterio-
rate patients have lower forced expiratory volume in one second (FEVi) values 
and are more hypennflated Because these parameters influence respiratory 
muscle strength, we investigated if maximal inspiratory pressures were lower 
during an exacerbation and if decreased inspiratory muscle strength contri-
buted to a decreased arterial oxygen saturation during the day and night in 
patients with moderate to severe COPD (chapter 6) 
In chapter 5 a significant correlation was found between respiratory muscle 
strength and nocturnal saturation Already has been shown that target-flow 
inspiratory muscle training (TF-IMT) improves respiratory muscle strength in 
patients with COPD13 Therefore, the aim of chapter 7 was to study the effects 
of TF-IMT on nocturnal saturation in patients with severe COPD 
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1.4 LIST OF ABBREVIATIONS 
BMI body mass index 
COPD chronic obstructive pulmonary disease 
di diaphragm 
EEG electroencephalogram 
EMG electromyogram 
EOG electrooculogram 
Fc centroid frequency of the EMG power spectrum 
FEVi forced expiratory volume in 1 second 
FIV1 forced inspiratory volume in 1 second 
FRC functional residual capacity 
HCVR hypercapnic ventilatory response 
HR heart rate 
IMT inspiratory muscle training 
mt intercostal muscles 
IVC inspiratory vital capacity 
KCO diffusion capacity for carbon monoxide 
NREM non-rapid eye movement 
O2 oxygen 
OSAHS obstructive sleep apnoea/hypopnoea syndrome 
Pdi maximal static inspiratory transdiaphragmatic pressure 
РаСОг partial carbon dioxide pressure in the arterial blood 
РаОг partial oxygen pressure in the arterial blood 
PEmax maximal static expiratory mouth pressure 
PetCÛ2 partial carbon dioxide pressure in the end-tidal expiratory air 
Pga maximal static inspiratory gastric pressure 
Plmax maximal static inspiratory mouth pressure 
Plmax,std maximal standardised static inspiratory mouth pressure 
Plmax,sup maximal static inspiratory mouth pressure in supine position 
Poes maximal static inspiratory oesophageal pressure 
Psniff maximal dynamic inspiratory mouth pressure 
Psniff.di maximal dynamic inspiratory transdiaphragmatic pressure 
Psniff,np maximal dynamic inspiratory nasopharyngeal pressure 
Psniff,oes maximal dynamic inspiratory oesophageal pressure 
Psniff.sup maximal dynamic inspiratory mouth pressure in supine position 
PTi pressure time index 
REM rapid eye movement 
RV residual volume 
SD standard deviation 
SEM standard error of the mean 
sit in the sitting position 
sup in the supine position 
TF-IMT target flow inspiratory muscle training 
Τι inspiration time 
Ttot total time of the respiratory cycle 
VdA/t relative dead space volume 
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CHAPTER 2 
2A.1 METHODS TO MEASURE RESPIRATORY MUSCLE STRENGTH, 
ENDURANCE AND FATIGUE 
Respiratory muscle strength, endurance and fatigue can be assessed in 
different ways, which will be discussed in this chapter Respiratory muscle 
strength can be assessed by measuring maximal inspiratory and expiratory 
pressures Presuming maximal cooperation and optimal coaching of the 
subjects, these pressure measurements are influenced by several factors, 
which are summarized in Table 1 
Table 1 
Factors influencing respiratory pressure measurements 
1 : Type of manoeuvre 
static or dynamic 
2: Measurement level, 
mouth nasopharynx oesophagus, transdiaphragmatic 
3: Lung volume at wich pressures are measured 
4: Mouthpiece 
6: Air leak of the system 
7: Number of efforts 
Θ: Methods used to measure transdiaphragmatic pressures, 
two separate balloons or a double-lumen catheter 
Respiratory muscle strength can be measured in a static way by performing 
maximal inspiratory and expiratory pressures against an occluded airway 1~3 
This test is tiring and subjects should be allowed to rest several minutes 
between efforts Despite careful coaching, some subjects are unable to 
coordinate adequately to perform maximal static inspiratory and expiratory 
pressures Therefore, Miller et al 4 described the dynamic sniff manoeuvre 
During this manoeuvre subjects perform short sharp sniffs, as hard as possi­
ble, without sustaining peak pressure This was found to be a useful manoeu­
vre, since it was easy to perform, reproducible and less tiring than the static 
manoeuvres Recently, new methods of evaluating respiratory muscle strength 
have been described, like twitch response to electrical phrenic nerve stimula­
tion 5 7 and cervical magnetic stimulation 7 θ The advantage of these methods 
is that they are independent of patient cooperation 
Maximal inspiratory pressures can be measured at different levels such as the 
mouth, nasopharynx, oesophagus and it can be measured transdiaphragmati-
7k 
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cally These levels influence the pressures measured In normal subjects and 
in patients with respiratory muscle weakness maximal dynamic inspiratory 
mouth pressure (Psniff) and maximal dynamic inspiratory nasopharyngeal 
pressure (Psmff.np) were lower than maximal dynamic inspiratory oesophageal 
pressure (Psniff.oes) 9 
Static and dynamic pressure values measured at the same level are not 
identical Maximal dynamic inspiratory transdiaphragmatic pressure (Psniff ,di) 
was higher than maximal static inspiratory transdiaphragmatic pressure (Pdi) 
4
 In contrast, Wanke et al 10 found that in normal subjects Psniff was lower than 
maximal static inspiratory mouth pressure (Plmax) values published by others 
1 211 
Also the lung volume at which the manoeuvre is performed influences respira­
tory pressures, since the length of the respiratory muscles and therefore the 
contractile properties vary with lung volume 1 0 1 2 1 5 The highest static inspira­
tory pressures are measured at residual volume (RV), while the highest expira­
tory pressures are measured at total lung capacity (TLC), because at these lung 
volumes the optimal length of the in- and expiratory muscles is reached Sniff 
pressures are often measured at functional residual capacity (FRC) An advan­
tage of measuring inspiratory pressures at FRC is that the net elastic recoil 
pressure of the thorax and lungs does not influence the results At levels below 
FRC, Plmax is somewhat overestimated due to the prevailing elastic recoil 
pressure of the thoracic wall ' 3 1 5 
The choice of mouthpiece, flanged or tubed, influences the measured respira­
tory pressures A tubed mouthpiece results in higher Plmax and maximal static 
expiratory mouth pressure (PEmax) values than a flanged mouthpiece 1 2 16 
This difference might be caused by the fact that the tubed mouthpiece requires 
the subjects to press the apparatus firmly against their mouth This requires 
activation and co-ordination of muscle groups that are not required when a 
flanged mouthpiece is used 
The air leak in the measurement system is another important factor An air leak 
is used to avoid pressure generated in the mouth by preventing closing of the 
glottis and the use of facial muscles How large such a leak should be, however, 
has not been agreed upon The larger the air leak, the lower the respiratory 
pressures are 17 
Body position is another factor that can influence pressure measurement In 
healthy subjects respiratory pressures are higher in the sitting than in the supine 
position 1θ 2 1 This is caused by the increased phasic and tonic activity of the 
scalene, sternocleidomastoid and parasternal-intercostal muscles and the 
increased compliance of the rib cage in sitting position in comparison to the 
supine position 1 9 2 2 
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The number of efforts needed to obtain a reproducible value of Plmax was 
determined by Fiz et al. 23. They concluded that In untrained and in unexperi-
enced patients with COPD a minimum of 9 manoeuvres should be performed. 
The method used to measure transdiaphragmatic pressures can influence the 
values. Transdiaphragmatic pressures can be measured by using the conven-
tional oesophageal and gastric balloons which are both inserted through the 
nose (Fig 1) or by one double lumen catheter which is also inserted through 
the nose (Fig 2). When using the double lumen catheter, one lumen has a distal 
Balloon catheters 
Pressure transducers 
Fig. 1 
Transdiaphragmatic pressure measurement 
performed with a two balloons catheter system 
opening at the gastric level and the other lumen has a more proximal opening 
at oesophageal level. The double lumen catheter is perfused with water at a 
constant low flow rate, preventing closing of the gastric and oesophageal 
openings. The advantage of using the double lumen catheter is that it is easier 
Double lumen catheters Pressure transducers 
Fig. 2 
Transdiaphragmatic pressure measurement 
performed with a double lumen catheter system. 
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to swallow by the subjects Kinnear et al 2 4 showed that Psniff ,di measured with 
a water perfused system gave higher values than Psniff.di measured with 
balloons 
All the above mentioned factors might be responsible for the differences in 
maximal respiratory pressure values found in the literature 
Measurement of respiratory muscle endurance is more complicated Respira­
tory muscle endurance is defined as the capacity of the respiratory muscles to 
generate and sustain a certain level of inspiratory pressure Sustained maximal 
voluntary ventilation 2 5 2 6 and resistive breathing are two types of endurance 
tests As these methods highly depend on flow rates, the breathing pattern 
should be strictly defined and controlled, otherwise subjects tend to adopt a 
non-fatiguing breathing pattern with low flow rates Therefore, a method was 
developed, called inspiratory threshold loading, in which a weighted plunger 
was used as an inspiratory valve (Fig 3) This ensures that a constant pressure 
is generated with each breath and allows the subjects to vary tidal volume freely 
2 /
 In this way the results are independent of flow rates 
Muscle fatigue is defined as a condition in which there is a loss in capacity for 
developing force or velocity of a muscle, which results from muscle activity 
Exspiration 
valve 
Pressure transducer 
fig. 3 
Incremental threshold loading device 
under load and which is reversible by rest 2 8 The mechanisms of fatigue are 
complex and involve changes at various sites within the muscle, the neuromus­
cular junction and the central nervous system Tests have been developed to 
measure the change from a non-fatigued unloaded condition to a fatigued state 
An example of such a test is measurement of the pressures generated by the 
inspiratory muscles with respect to maximal pressures and duty cycle (ι e the 
duration of the inspiration as a fraction of the duration of the total respiration) 
The pressure time index (PTi) was defined as the product of the mean transdia­
phragmatic pressure developed during contraction divided by Pdi and the 
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duration of contraction (Τι) divided by the total duration of the respiratory cycle 
(Ttot) (duty cycle) Bellemare et al 2 9 3 0 showed that the critical PTi of the 
diaphragm for normal subjects is 0 15 This means that when PTi is higher than 
0 15, fatigue occurs The PTi of the rib cage muscles was recently studied by 
Zocchi et al 3 1 They found that the fatigue threshold for these muscles was 
0 30 Another method of measuring fatigue is an experiment in which changes 
in the power spectrum of the electromyogram (EMG) of the diaphragm or 
intercostal muscles are measured during a fatiguing experiment When fatigue 
occurs, there is a shift in the power spectrum of the EMG from high to low 
frequencies This can be measured as a relative increase in the power of the 
low-frequency EMG and a decrease in the high-frequency power of the EMG, 
which results in a decrease of the high-to-low ratio and in the median (centroid) 
frequency of the power spectrum 32~34 
2A.2 RESPIRATORY MUSCLE FUNCTION IN PATIENTS WITH COPD 
Maximal inspiratory pressures are often reported to be lower in patients with 
COPD than in healthy subjects 1 2 3 5 3 7 However, some authors suggest that 
Plmax is normal after correction for lung volume 5 Э Э '4 0 and Byrd and Hyatt41 
even reported an increased Plmax Respiratory muscle strength and endur­
ance are influenced by mechanical factors such as lung volume and body 
position and non-mechanical factors such as age 1 2, height 2, weight 2 42, 
sustained overload 43, hypoxemia 44, hypercapnia 4 5 and the use of cortico­
steroids 4 6 
Pressure generation by the diaphragm is influenced by the length of the 
diaphragm 1 3 1 5 Hypennflated patients have a more shortened diaphragm, 
which works at a more unfavourable position on the length-tension curve and 
therefore generate lower inspiratory pressures 3 6 In theory it is possible to 
influence the length of the diaphragm in patients with COPD by changing 
position from sitting to supine This was shown for the canine diaphragm 4 7 In 
supine position, the flattened diaphragm will be displaced upwards by the 
abdominal contents and it will therefore be in a more advantageous position 
on the length-tension curve Higher transdiaphragmatic pressures might there­
fore be expected in supine position This would be in contrast to healthy 
subjects in whom Pdi is lower in supine position 2 0 
Malnutrition may be important in patients with COPD because malnutrition 
reduces respiratory muscle strength and maximal voluntary ventilation 4 8 4 9 
This is probably related to the fact that subjects who are underweight have a 
lower diaphragmatic muscle mass and thickness 4 2 Refeedmg of malnour­
ished patients leads to improvement of respiratory muscle strength 5 0 
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A sustained overload, expressed by a decrease in FEVi, may also contribute 
to the impairment of respiratory muscle function 43 
The effects of hypoxia and hypercapnia on muscle performance have only been 
investigated in the acute situation The effects of chronic changes in blood 
gases, as in patients with COPD, is not known The instant effect of administered 
oxygen seems to delay the onset of fatigue in normal subjects 51 Hypoxia 
results in a shorter endurance time, a faster shift to the left of the power spectrum 
of the EMG and in a greater increase in blood lactate concentration 44 Acute 
hypercapnia (end-tidal PCO2 >7,5%) reduces contractility of the diaphragm in 
healthy subjects, whereas hypocapnia had no effect45 
Corticosteroids may induce myopathy of the respiratory muscles with reduction 
in Plmax and PEmax values 46 
2A.3 INSPIRATORY MUSCLE TRAINING 
Respiratory muscle strength and endurance can be improved by inspiratory 
muscle training (IMT) Four types of training have been described 
1) Voluntary isocapnic hyperpnoea5253 
In this type of training patients perform two or three runs of maximally sustained 
ventilatory capacity of 15 minutes under normocapnic conditions each day A 
disadvantage is that this can only be done under laboratory conditions 
2) Inspiratory flow resistive training 54 63 
In this form of training patients breathe through a valve in which the caliber of 
the inspiratory orifice can be changed By making the caliber of the orifice 
smaller the inspiratory effort has to increase However, the inspiratory pressure 
depends on the inspiratory flow The latter should be controlled during a training 
programme, otherwise a nonfatiguing breathing pattern will be adopted 
3) Inspiratory threshold loading 6A 6e 
In this technique, an inspiratory valve is loaded with a spring or with weights 
Thus, a certain level of inspiratory pressure has to be generated in order to 
overcome the threshold load and to initiate air flow 
4) Target-flow and target-pressure inspiratory muscle training 67 70 
In this form of training patients are instructed to generate an inspiratory flow rate 
through a fixed resistance67 68 The flow is measured from the level of a ball in 
an incentive flow meter In target pressure training, the subjects are instructed 
to inspire with a force sufficient to generate a target pressure 69 In this way there 
is a breath-to-breath visual feedback of training intensity, in contrast to the 
above described training methods 
Leith and Bradley 71 were the first investigators who showed that inspiratory 
muscle strength and endurance could be improved by IMT in normal subjects 
However, the results of IMT in patients with COPD are conflicting Some studies 
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show an increase of Plmax and/or endurance 5 3 5 5 5 6 5 8 5 9 6 1 6 4 6 5 6 7 6 8 72, while 
other studies could not find a positive result 5 7 6 0 6 2 Several factors may play 
a role in explaining the different results 
1) During inspiratory flow resistive training, inspiratory flow, breathing pattern 
and inspiratory pressure were often not defined 62 
2) Patient compliance was not assured 6 2 
3) No selection criteria were defined which patients should tram their inspiratory 
muscles 
4) No control group was present52 5 5 5 7 ω 
5) The duration of the total training period varied from 4 weeks5e to 6 months62 
7) There were differences in training frequency, duration and intensity 
8) Sometimes small numbers of patients were enrolled 5 3 7 2 
Therefore, in our intervention study (chapter 7) in which we studied the effects 
of target-flow inspiratory muscle training (TF-IMT) on nocturnal saturation, 
methods were precisely defined and patients were selected very carefully They 
were in a stable condition as defined by no more change in FEVi than 10% 
during the past half year The mean nocturnal arterial oxygen saturation had 
to be lower than 92% Patients with other pulmonary diseases, chest wall 
deformations, a previous thoracotomy, diabetes mellitus, neuromuscular dis­
eases, angina pectoris, obstructive sleep apnoea syndrome (OSAS) or an 
overlap syndrome were excluded Twenty patients had TF-IMT during 10 
weeks Ten patients trained at 60% of their Plmax and the other 10 received 
sham-training at 10% of their Plmax A target-flow inspiratory muscle training 
device was used In and expiration time lasted 3 and 4 seconds respectively 
The patients trained two times a day during 15 minutes Every week Plmax was 
checked and the training device was adjusted if necessary and every week a 
physiotherapist checked if the training manoeuvres were performed ade­
quately 
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2B.1 METHODS TO MEASURE NOCTURNAL SATURATION 
Breathing disorders and there underlying mechanisms can be assessed by 
polysomnography During the night arterial oxygen saturation, carbon dioxide 
tension, thoracoabdominal movements and sleep stages are recorded1 Arte­
rial oxygen saturation and heart rate are measured with a pulse oximeter 
Carbon dioxide tension can be measured transcutaneously or by sampling 
end-tidal air Thoracoabdominal movements are measured by inductive 
plethysmography Sleep stages are defined by electroencephalography, elec­
tromyography according to the guidelines of Rechtschaffen and Kales 2 and/or 
by electrooculography according to the European Consensus1 They are used 
to define the adequancy of sleep, ι e is there enough sleep to be repre­
sentative, and conformation of REM sleep to catch the presence of REM sleep 
related phenomena1 
When analysing polysomnography records, several irregular breathing pat­
terns can be distinguised Central apnoea is defined as the absence of PCO2 
oscillations or oro-nasal airflow for at least 10 seconds, in combination with 
absent chest wall movements 3 Obstructive apnoea is defined as the absence 
Sa02(%) 100 
Thoracic 
movements 
figure 4 An example of obstructive sleep apnoea syndrome 
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of PCO2 oscillations or oro-nasal airflow for at least 10 seconds, in combination 
with a normal or decreased chest wall movement4 (Fig 4) Hypopnoea is defined 
as an episode of alveolar hypoventilation of at least ten seconds The gold 
standard for hypoventilation is an increase in arterial (end-tidal) PCO2 Since 
this is a difficult parameter to measure, several authors define hypopnoea by a 
change in the amplitude of chest wall movement by one half3 However, one 
should bear in mind that changes in posture (lateral to supine or vice versa) will 
also drastically change the amplitude of the movements of the thoracic wall, 
without any change in actual ventilation Central hypopnoea is caused by a 
decrease in central ventilatory drive and ideally it should be deduced from a 
parameter that measures ventilatory drive more or less directly Integrated 
respiratory muscle EMG or oesophageal pressure oscillations are such pa-
rameters Indirect parameters of a decrease in ventilatory drive, such as 
movements of the thoracic wall, should be interpreted with extreme caution 
The term 'central hypoventilation' is often used to indicate hypoventilation of a 
non-obstructive origin, such as respiratory muscle failure, although the latter is 
no central problem in the strict sense Obstructive hypopnoea is associated with 
a normal or even increased central ventilatory drive and decreased ventilation 
Also in this situation, the amplitude of the thoracic wall movements will be 
decreased In this study, hypopnoea will be defined according to Catterall et al 
3
, when the amplitude of the thoracic wall movements is halved during an 
episode of ten seconds This should be accompanied by an increase in 
end-tidal PCO2 We assume that such a hypoventilation period is centrally 
mediated, if it occurs during REM sleep There is ample evidence that during 
this sleep stage hypoventilation occurs due to non-obstructive mechanisms 
(Fig 5) A combination of a central and an obstructive breathing disorder might 
also be present 
2B.2 NOCTURNAL ARTERIAL OXYGEN SATURATION IN PATIENTS 
WITH COPD 
In many patients with COPD, transient decreases in nocturnal arterial oxygen 
saturation occur 3 5 9 This may be caused by a variety of factors The impor-
tance of these factors will be outlined below 
Hypoventilation ('central hypopnoea') During sleep, ventilation is reduced in 
normal subjects and in patients with COPD 1014 This hypoventilation is most 
severe during REM sleep The cause of this phenomenon is not fully understood 
but may be related to a decrease of brain stem respiratory activity15, diminished 
respiratory responses to hypoxia1617 and hypercapnia1B19 during REM sleep 
(although Warley et al 20 did not find impaired hypercapnic responses during 
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REM sleep) and, a loss of inspiratory activity of intercostal muscles 21"23 and 
accessory respiratory muscles 24. The latter is due to the REM-sleep-related 
supraspinal inhibition of the gamma motor neuron drive. Since the gamma 
motorneuron innervation of the diaphragm is sparse, this muscle is relatively 
Sa02(%) 100 
End-tidal 4 0 
CO2 
КРа г о 
Figure S Ал example ol non obstructive hypoventilation 
spared. These changes occur in patients with COPD as well as in healthy 
subjects, but the consequences are worse in the first group. Firstly, patients 
with COPD often have somewhat lowered arterial oxygen tensions awake. The 
starting position on the oxygen saturation curve is closer to the steep part, so 
a small drop in РаОг during the night causes a large fall in БаОг. Secondly, 
the flattened diaphragm cannot compensate for the decreased activity of 
intercostal and accessory muscles during REM sleep. Thirdly, desaturating 
patients have a larger decrease in functional residual capacity during hypo-
pnoea10. Finally, the ventilatory responses in some patients with COPD during 
wakefulness are already be lowered 25"27, further contributing to the degree of 
nocturnal desaturations. 
Ventilation/perfusion inequality: Previously, this has been considered as the 
major cause of REM-sleep-related hypoxemia in patients with COPD 6 · 2 8 . 
However, these studies were based on the assumption that there is a steady 
state of gas transfer, which does not exist during REM sleep14·23. It is inevitable 
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though that hypoventilation during REM sleep is accompanied by some altera­
tion in ventilation/perfusion matching 
Cough Power et al & showed that cough did not happen during REM sleep 
and cannot be responsible for the desaturating events So, mucus-plugged 
airways are more likely to occur and contribute to ventilation-perfusion mis­
match 
Abnormal hypercapmc and hypoxic responses Ventilatory responses during 
wakefulness to hypercapnia and hypoxia seem to be lower in hypoxic patients 
25 27 30 31 
Obstructive sleep apnoea/hypopnoea syndrome (OSAHS) OSAHS, defined as 
a sleeping disorder in which obstructive apnoea/hypopnoea events occur more 
than ten times per sleeping hour, may affect 1 -4% of the general population 
3 2 3 3
 So, a similar percentage of patients with COPD may also suffer from 
OSAHS, but the prevalence is most probably not higher than in the general 
population 3 
2B.3 POSSIBLE CONSEQUENCES OF NOCTURNAL HYPOXEMIA 
When desaturations are severe and result in nocturnal hypoxemia, side effects 
may occur Nocturnal hypoxemia is associated with pulmonary hypertension 
34 36( whiCh causes cor pulmonale
 3 7 3 8
 Furthermore, polycythemia may exist 
3 9 4 0
 Cardiac arrhythmia is an uncommon complication, but premature ven­
tricular complexes, bradycardia and tachycardia have been described41 4 2 The 
data on effects of nocturnal hypoxemia on survival are conflicting and hard to 
compare In the study of Connaughton and colleagues 4 3 97 patients with 
severe COPD and a mean daytime РаОг of 7 3 kPa were included Patients 
who were more hypoxemic at night than predicted from the regression relation­
ship during the day, had a survival simular to that of the patients who were less 
hypoxemic than predicted from the same regression equation In the regression 
relationship, daytime Sa02 was the only predictive variable These authors 
concluded that the severity of nocturnal hypoxemia did not influence the 
prognosis However, in their study many patients were already hypoxemic 
during the day, so that effects of nocturnal hypoxemia alone on survival could 
not be estimated In contrast, Fletcher and coworkers 4 4 showed in 169 patients 
with COPD and a mean FEVi of 35% predicted, who were all normoxemic 
(daytime РаОг >8 0 kPa) that desaturating patients during the night had a 
worse survival than non-desaturatmg patients (mean survival 2 9 (1 7) and 3 7 
(1 7) years, respectively) Also, 5-year survival was also significantly better in 
the non-desaturatmg group (after stratification for oxygen suppletion) However, 
this was a retrospective multi centre study, in which patients were included who 
were already treated with oxygen 
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2B.4 TREATMENT OF NOCTURNAL HYPOXEMIA 
Supplemental oxygen 
Studies on the effects of oxygen have only been performed in patients who 
were also hypoxemic during the day In these studies an improvement of the 
quality of live 45, some reversal of ECG changes (less right axis deviation or 
the loss of the finding of 'p-pulmonale' 45) and a decrease of the pulmonary 
artery pressure combined with an increase of the cardiac output 4 6 were 
observed Supplemental oxygen during the night can be given safely, because 
it improves the nocturnal oxygenation with only a small rise in РаСОг 4 7 No 
studies are available describing the effects of oxygen therapy for nocturnal 
hypoxemia only on the above mentioned complications Although, in the above 
mentioned study of Fletcher and coworkers 4 4 the effects of oxygen on survival 
in the desaturating group showed only a trend towards shorter survival in the 
non-oxygen treated group However, neither the amount of oxygen adminis­
tered nor the effects of oxygen on nocturnal saturation were described 
Nocturnal oxygen supply should be titrated individually during a full night and 
should be controlled by oximetry The mean nocturnal arterial oxygen satura­
tion should be more than 90% 
Ventilatory stimulants 
Stimulating agents may be considered, if any reserve-capacity of the ventilatory 
pump is present The progestatives medroxyprogesterone acetate and chlor-
madione acetate increased daytime РаОг and decreased РаСОг, but the 
effects on nocturnal saturation were marginal or absent in the whole group of 
patients Yet, for the individual patient chlormadione acetate may have a 
substantial positive effect on day- and nighttime blood gas values 4 8 Almitrme 
bismesylate, a peripheral chemoreceptor stimulant, improved arterial blood 
gas tensions awake and asleep, but did not improve sleep quality 4 9 It may 
even cause an increase in pulmonary artery pressure in patients with COPD, 
as shown by MacNee and colleagues 5 0 A rise of the pulmonary artery 
pressure was found in all patients treated with Almitrme, with a mean increase 
of 10 mm Hg Acetazolamide, a carbonic anhydrase inhibitor, stimulates 
ventilation presumably by inducing metabolic acidosis In a one-week double-
blind, placebo-controlled study, it caused an improvement in the mean daytime 
РаОг of 1 9 kPa and in the mean nocturnal saturation of 4% 5 1 However 
acetazolamide may be ineffective in some patients Daytime parameters 
however, failed to select the non-responders Recently, Mulloyetal 5 2 showed 
in a three-week double-blind, placebo-controlled study, that theophylline im­
proved gas exchange during sleep in 10 patients with severe COPD The mean 
Z& 
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Sa02 asleep improved by 2% while the mean transcutaneous^ measured PCO2 
asleep decreased by 0 5 kPa 
Assisted ventilation 
Continuous positive pressure ventilation during the night, administered through 
a nasal mask, can effectively reduce inspiratory muscle effort during sleep, but 
SaCte and transcutaneously measured PCO2 were unaffected 5 3 The effects of 
nasal intermittant positive pressure ventilation during the night were described 
in an uncontrolled study by Carroll and coworkers 5 4 They showed in four 
hypoxemic patients with COPD and a mean FEV1 of 19 % of the predicted value 
that daytime Pa02 did not change significantly while daytime РаСОг decreased 
(1 1 kPa) Oxygenation during the night improved This was shown by a 
decrease of the time spent below 90% ЭаОг from 100% to 40% of the total 
monitoring time However, the patients slept less well, as shown by a decrease 
of REM sleep from 12 % to 5 % of the monitoring time 
2B.5 CLINICAL CONSEQUENCES AND RECOMMENDATIONS 
Although positive effects of the different forms of therapy on nocturnal saturation 
have been described, no placebo-controlled studies have been published on 
the effects on pulmonary artery pressure, cor pulmonale and survival of an 
increased oxygenation during the night by supplemental oxygen, ventilatory 
stimulants or assisted ventilation Therefore, so far it is not recommended to 
prescribe oxygen to patients with mild nocturnal hypoxemia only, since it is an 
expensive form of therapy An exception is made for two groups of patients with 
COPD First, patients with nocturnal hypoxemia, a daytime РаОг between 7 3 
- 8 0 kPa and evidence of cor pulmonale or polycythemia Second, patients with 
severe hypoxemia (Sa02< 85%) during more than 2 hours while sleeping, 
because it is unlikely that such episodes are harmless Acetazolamide, proges­
tatives and theophyllines are modalities that can be used to treat nocturnal 
hypoxemia, but their effects on the occurence of complications in the long term 
are not known 
Based upon the above mentioned considerations nocturnal hypoxemia (Sa02< 
90%) in patients with COPD should be treated in the following way 
Supplemental oxygen for as close to 24h/day as possible 5 5 should be 
administered if 1, nocturnal hypoxemia (Sa02< 90%) is present in combination 
with daytime hypoxemia (РаОг< 7 3 kPa) measured in a stable period and 
when 2, nocturnal hypoxemia is present in combination with a daytime Pa02 
between 7 3-8 0 kPa with evidence of polycythemia (Ht >55%) or right heart 
failure Nocturnal oxygen therapy may be considered in patients with severe 
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episodes of hypoxemia (Sa02< 85%) during more than 2 hours of the night 
The oxygen dose should be sufficient to raise the saturation above 90% 
Acetazolamide, progestatives and theophyllines may be considered to treat 
patients with mild hypoxemia during the night The response to these medica­
tions should be assessed individually by polysomnography or oximetry 
Whether respiratory muscle training can be used to treat nocturnal hypoxemia, 
is one of the subjects of this thesis 
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Differences between sniff mouth pressures and static maximal Inspiratory mouth pressures 
3.1 ABSTRACT 
Measurements of static maximal inspiratory mouth pressure (Plmax) and 
dynamic sniff mouth pressure (Psniff) are frequently used to assess inspiratory 
muscle strength The aims of the present study were to examine in 42 healthy 
subjects the equivalence of Plmax and Psniff, the influence of body posture on 
Plmax and Psniff, and the effects of nasal patency and repeated manoeuvres 
on Psniff 
Plmax was significantly higher than Psniff, 11 1 (0 4) kPa versus 8 5 (0 3) kPa 
Because of the low agreement between Plmax and Psniff, the two measure-
ment methods were not interchangeable The limit of agreement was 2 6 (3 9) 
kPa Sitting inspiratory pressures were higher than supine inspiratory pres-
sures Sitting Plmax was 11 1 (0 4) kPa and supine Plmax was 9 4 (0 4) kPa 
Sitting Psniff and supine Psniff were 8 5 (0 3) kPa and 7 5 (0 3) kPa, respec-
tively Psniff performed with one nostril open instead of two, was higher 9 7 
(0 3) kPa left and 9 6 (0 3) kPa right, versus 8 5 (0 3) kPa when both nostrils 
were open After 20-28 sniff manoeuvres Psniff fell from 8 4 (0 3) kPa to 7 8 
(0 3) kPa , suggesting some mechanism of inspiratory muscle fatigue 
We conclude that measurement of sitting Plmax yields the highest values for 
inspiratory muscle strength The two measurement methods, Psniff and Plmax, 
are not interchangeable Measurement of Psniff is affected by nasal patency 
3.2 INTRODUCTION 
Measurement of maximal static inspiratory and expiratory pressures is an 
accepted clinical method for evaluating strength of the respiratory muscles1 4 
Another method to assess respiratory muscle function is the dynamic sniff 
manoeuvre The respiratory static and dynamic pressures can be measured 
at the mouth, nasopharynx (np), oesophagus (oes) and transdiaphragmatic 
level (di) Koulouns et al5 showed that Psniff mouth (Psniff) and Psniff naso-
pharynx (Psniff.np) were slightly lower than Psniff oesophagus (Psniff,oes) in 
normal subjects and in patients with inspiratory muscle weakness In ten 
patients, static maximal inspiratory mouth pressures (Plmax) were found to be 
in the same range as Psniff Psniff in ten healthy subjects was in the same 
range as Plmax reported by others Laroche et al 6 investigated 61 patients 
referred with suspected respiratory muscle dysfunction Psniff,oes and 
Psniff.di were found to be higher than Plmax and maximal static inspiratory 
transdiaphragmatic pressure (Plmax.di) Miller et al7 compared oesophageal 
(Poes) and transdiaphragmatic pressures (Pdi) during both manoeuvres in 
healthy volunteers These authors showed that Psniff was higher, had a 
narrower range of reference values, and was more reproducible than static 
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Plmax Therefore, they concluded that maximal sniff is a natural manoeuvre, 
easily performed and repeatable without fatiguing In contrast, Wanke and 
colleagues 8 found Psniff at residual volume (RV) to be less negative than Plmax 
reported by other authors 1 3 To our knowledge, a comparison between Psniff 
and static Plmax within the same healthy subject has not yet been studied 
Static Plmax and PEmax in sitting and semi-recumbent position have been 
studied in normal subjects by Ng and Stokes 9 They demonstrated that body 
posture did not affect Plmax and PEmax In contrast, Psniff.oes measured in 
supine position was found to be less negative than when measured in sitting 
and semi-recumbent position 1 0 
Accurate measurement of inspiratory muscle strength in patients with pulmo­
nary diseases is important for assessing the causes of impending respiratory 
failure Because of the discrepancies in the literature about the factors that may 
influence this measurement, the purposes of this study were to investigate 1) 
whether measurement of Psniff is equivalent to static Plmax at residual volume, 
2) the effects of nasal patency on Psniff, 3) the effects of body position, and 4) 
whether signs of fatigue occurred after repeated sniff manoeuvres 
3.3 METHODS 
Pressure measurements 
The apparatus and procedure to measure Plmax and PEmax were based on 
those used by Black and Hyatt1 A plastic flanged mouthpiece was connected 
to a closed, rigid, plastic tube with a small leak (ι d 1 1mm, length 40mm), 
preventing buccal muscles from producing significant pressures and closing 
of the glottis The pressure inside the tube was measured with a pressure 
transducer (range ± 40 kPa)(Vahdyne DP15-34) and recorded on an ink-writing 
recorder (Kipp en Zonen BD 101, Delft, Netherlands) 
Psniff was measured with a flexible open-tipped catheter (ι d 1 8mm)1 1 1 2 The 
tip of the catheter was positioned in the oral cavity, as close as possible to the 
posterior wall of the pharynx 5 θ Calibrations were made before each measure­
ment with a water manometer The 95% response time of the Pmo catheter 
system was 0 03 sec The subjects could see the recordings, and were 
encouraged to generate maximal deflections 
Subjects and protocol 
Forty two healthy subjects (21 female, 21 male) participated in this study The 
mean age was 42 3 (1 8) years (range 23-68 years), height 1 74 (0 02) m, weight 
71 1 (1 9) kg Plmax was measured at RV, in sitting and supine position, in 
random order PEmax was measured in sitting position at total lung capacity 
(TLC) The subjects were wearing a noseclip Care was taken to maintain an 
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identical posture and appropriate support tor the arms, throughout the experi­
ment in either position. The manoeuvre was repeated at least three times, until 
three reproducible measurements had been obtained, with a maximal variabil­
ity of 10% 13. Pressures had to be maintained for two seconds to be able to 
measure the plateau pressure. The highest plateau pressure value was used 
for analysis. 
Table 1 
Maximal respiratory mouth pressures during static and dynamic efforts 
Variable 
Psniff (kPa) 
Psniff-begin (kPa) 
Psniff-end (kPa) 
Psniff-left (kPa) 
Psniff-right (kPa) 
PImax (kPa) 
PImax (pred) 
PEmax (kPa) 
PEmax (pred) 
Male 
mean (SEM) 
Sitting Supine 
9 4 (0 4) 8 3 (0 5) 
9 2 (0 4) 
θ 5 (0 4) 
10 3(0 5) 
10 6(0 4) 
12 4(0 6) 10 7(0 6) 
9 8 (0 2)* 
141 (0 9) 
14 3(0 3)* 
Female 
mean (SEM) 
Sitting Supine 
7 7 (0 4) 6 7 (0 4) 
7 6 (0 4) 
7 1 (0 4) 
9 1 (0 4) 
8 6 (0 4) 
9 7 (0 4) 8 1 (0 4) 
7 7(0 2)* 
10 2(0 7) 
9 5 ( 0 1 ) * 
Psniff highest dynamic sniff mouth pressure pettormed with open nose, Psniff-begin Psniff at the beginning of a ses­
sion. Psniff-end Psniff at the end. Psniff-left Psnilf with left nostril open, Psntff-nght Psniffwith nght nostril open, PI­
max static maximal inspiratory mouth pressure, PEmax static maximal expiratory mouth pressure, PImax (pred) and 
PEmax (pred) reference values according to Wilson et al2 
* Residual SEM after correction for sex, age and height 
The subjects were asked to perform maximal short sharp sniffs through the 
nose, from RV, with the mouth closed. Between the sniffs there was a pause 
of at least two quiet breaths lasting 10 s. The sniffs were repeated until Psniff 
did not increase further. This was usually the case within 8 sniffs. Subsequently, 
all subjects performed 6 sniffs from RV with both nostrils open in sitting 
(Psniff-begin) and supine position, which was measured in random order in 35 
of the 42 patients. Then the subjects performed 6 sniffs from RV with one nostril 
closed,followed by 6 sniffs with the other nostril closed. After that, they again 
performed 6 sniffs in a sitting position through the unoccluded nose, to test 
z£ 
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whether the sniff pressures changed (Psniff-end). Between the various sniff 
manoeuvres, a check was made that the catheter system was free of mucus. 
The highest Psniff values were selected for analysis. 
Preceding all manoeuvres, the mouth pressure at the end of the expiration or 
inspiration was arbitrarily set at zero, for inspiratoy and exspiratory pressures 
respectively. 
Data analysis 
Results are expressed as means ± SEM. Differences were tested by means of 
the Wilcoxon signed ranktest, corrected for multiple comparison by Bonferoni. 
A p-value of 0.01 was considered to be significant. The statistical method for 
assessing the agreement between Psniff and Plmax was performed according 
to Bland and Altman.14 
3.4 RESULTS 
The data for respiratory muscle strength of males and females are shown 
separately in Table 1. 
Static maximal inspiratory mouth pressures were higher than dynamic sniff 
Plmax (kPa) , 
18 
15 
12 
9 
6 
3 
0 
0 3 6 9 12 15 18 
Psniff (kPa) 
Figure 1 The relationship between static and dynamic mouth pressure of alt subjects The solid line represents the 
line ol identity Plmax static maximal inspiratory mouth pressure, Psnitl dynamic snilt mouth pressure 
48 
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pressures performed with one as well as with two nostrils open. Plmax was 
11.1 (0.4) kPa and Psniff was 8.5 (0.3) kPa (p<0.00005). Psniff with the left 
nostril open (Psniff-left) was 9.7 (0.3) kPa (p=0.002) and Psniff with the right 
nostril open (Psniff-nght) was 9.6 (0.3) kPa (p=0.002).The relationship between 
Plmax and Psniff is shown in Figure 1. A plot of the difference between the two 
methods against their mean is shown in Figure 2. The mean difference (d) was 
2.6 (0.3) kPa. The limits of agreement were (SD: standard deviation): 
6 9 12 15 1Θ 
Average inspiratory pressure 
by two methods (kPa) 
Figure 2 The difference between Psniff and Plmax against mean lor 
inspiratory mouth pressure data For abbreviations see legend to Figure 1 
Upper limit: d + 2.SD = 2.6 + (2 * 2.0) = 6.6 kPa 
Lower limit: d - 2.SD = 2.6 - (2 * 2.0) = -1.4 kPa 
Thus, Psniff can be 6.6 kPa below or 1.4 kPa above Plmax. 
The 95% confidence interval of the bias was: 
d ± 2.SEM = 2.6 + (2 * 0.3) = 3.2 kPa and 2.6 - (2 * 0.3) = 2.0 kPa 
The SEM of the upper limit and lower limit was V(3.SD2/n) = 0.5 kPa. 
The 95% confidence interval of the upper limit was: 
6.6 ± 2.SEM = 6.6 + (2 * 0.5) = 7.6 kPa and 6.6 - (2 * 0.5) = 5.6 kPa. 
The 95% confidence interval of the lower limit was: 
-1.4 ± 2.SEM = -1.4 + (2 * 0.5) = -0.4 kPa and -1.4 - (2 * 0.5) = -2.4 kPa. 
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The mean difference (d) between Plmax and Psniff-left was 1.4 (0.3) kPa. A plot 
of the difference between Plmax and Psniff-left and their mean is shown in 
Figure 3. The limits of agreement were: 
Upper limit: d + 2.SD = 1.4 + 2 * 2.1 = 5.6 kPa 
Lower limit: d - 2.SD = 1.4 - 2 * 2.1 = -2.8 kPa 
Psniff-left can be 5.6 kPa below or 2.8 kPa above Plmax. 
The 95% confidence interval of the bias was: 
d±2.SEM = 1.4 + 2*0.3 = 2.1 kPa and 1.4 - 2 * 0.3 0.8 kPa 
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Figure 3 The difference between Psniff-leñ and Plmax against mean lor Plmax and Psniff-left 
Psniff-left dynamic sniff mouth pressure with left nostril open, Plmax static maximal inspiratory mouth pressure 
The mean difference (d) between Plmax and Psniff-right was 1.4 (0.3) kPa. A 
plot of the difference and their mean between Plmax and Psniff-right is shown 
in Figure 4. The limits of agreement were: 
Upper limit d + 2.SD = 1.4 + 2 * 2.0 = 5.4 kPa 
Lower limit d - 2.SD = 1.4 - 2 * 2.0 = -2.6 kPa 
Psniff-right can be 5.4 kPa below or 2.6 kPa above Plmax. 
The 95% confidence interval of the bias was: 
d ± 2.SEM, 1.4 + 2 * 0.3 = 2.0 kPa and 1.4 - 2 * 0.3 = 0.8 kPa. 
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Psniff dynamic sniff mouth pressure performed with open nose, Psnilf-begin Psniff at a beginning of a session, 
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Psniff performed with two nostrils open (8.5 (0.3) kPa) was lower than Psniff with 
one nostril open, left: 9.7 (0.3) kPa (p<0.00005); and right 9.6 (0.3) kPa 
(p=0.0001)(Fig5). 
Static Plmax and Psniff were both significantly lower in the supine position. 
Sitting Plmax was 11.1 (0.4) kPa , and supine Plmax was 9.4 (0.4) kPa 
(p<0.00005). Sitting Psniff was 8.5 (0.3) kPa, and supine Psniff was 7.5 (0.3) 
kPa (p=0.0001) (Fig 6). The maximal expiratory mouth pressure (PEmax) in 
sitting position was 12.1 (0.6) kPa. 
After 20-28 sniff manoeuvres Psniff decreased from 8.4 (0.3) kPa (Psniff-begin) 
to 7.8 (0.3) kPa (Psniff-end) ( p=0.0007) (Fig 5). 
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Figure 6 Comparison of static and dynamic mouth pressures ol all subjects, in sitting and 
supine position (means + SEM¡ Psnilf.sup Psniff in supine position, Plmax,sup Plmax in supine position 
For other abbreviations see legend to Figure 1 
3.5 DISCUSSION 
This study showed a low agreement between static Plmax and dynamic Psniff 
performed with one or two nostrils open; static Plmax was significantly higher 
than dynamic Psniff. Psniff with one occluded nostril was significantly higher 
and closer to Plmax, than with two open nostrils. Consequently, the results of 
Psniff measurements can be influenced by nasal congestion. Pressures in 
sitting position were higher than those in supine position, and Psniff decreased 
after 20-28 manoeuvres. 
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When comparing Plmax and Psniff, the 95% confidence intervals were wide, 
reflecting the wide variation of the differences between the two measurements 
The two types of measurement were not interchangeable When comparing 
Plmax and Psniff with only the left or right nostril open, the mean difference 
was smaller, but the limits of agreement did not improve, so the different 
measurement methods were still not exchangeable 
Static Plmax was significantly higher than dynamic Psniff An explanation for 
the observed difference may be the force-velocity and length-tension relation­
ships of the respiratory muscles 15"19 When performing static pressure ma­
noeuvres, there is a minimal airflow through the leak, which may result in a 
higher pressure because of the force-velocity relationship Also, the change in 
volume will be smaller, resulting in less decrease of diaphragmatic length and 
a higher pressure because of the length-tension relationship Another mecha­
nism that may explain these higher static pressures compared to the dynamic 
pressures, may be the topical anaesthesia used by others When other 
investigators measured Pmo, simultaneous measurement of Pdi, Poes or Pnp 
was achieved by inserting a catheter through the nose Usually, topical 
anaesthesia was used 5 7 θ In the present study the catheter was placed 
directly in the mouth Thus, there was no need for local anaesthesia It may be 
hypothesized that pain or nasal discomfort when performing multiple sniff 
manoeuvres, could result in submaximal efforts and lower pressures Some 
subjects complained about a painful nose after many sniffs 
Sniff pressures were often reported to be higher than static pressures 6 7 
Wanke et al 8 were the only authors who found lower Psniff values However, 
none of these authors compared both procedures in the same subjects Wanke 
et al 8 also showed that sniff pressures were highest at RV Because of this 
finding, we chose to measure Psniff from RV instead of the more conventional 
functional residual capicity (FRC) level At levels below FRC, inspiratory muscle 
strength will be overestimated due to the elastic recoil pressure of the thorax 
1 6 2 0
 This, however, holds for the sniff pressures as well as the static maximal 
inspiratory pressures Héritier et al 21 found no difference between non-static 
peak maximal inspiratory mouth pressures and Psniff, in patients with acute 
respiratory failure The correlation coefficient between these two measure-
ments was 0 60 Similar correlations between static and dynamic pressures 
were found in patients with suspected respiratory muscle weakness 6 How-
ever, the correlation coefficient measures the strength between the two pres-
sure measurements and not the agreement14 
There is a very wide range of Plmax and PEmax values in several studies The 
most comprehensive studies were done by Rmgqvist3, Black and Hyatt1 and 
Wilson et al 2 The mean Plmax values were 13 0 (0 3) kPa, 12 4 (0 3) kPa and 
10 6 (0 5) kPa, respectively The mean PEmax values were 23 7 (0 6) kPa, 23 3 
7k 
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(0 6) kPa and 14 8 (0 5) kPa, respectively We used the prediction values 
according to Wilson et al 2, because these authors used a flanged mouthpiece 
The fact that our inspiratory values, measured with a flanged mouthpiece, are 
close to the reference values of Black and Hyatt1, which were measured with 
a tubed mouthpiece, suggests that the shape of the mouthpiece is of less 
importance 22 The expiratory pressures were in the same range as measured 
by Wilson et a l2 The subjects in the study of Ringqvistэ were pushed so hard 
that they suffered from spontaneous nose bleeds and conjunctival haemor­
rhages as a result of their efforts Normal values for Psniff are not available The 
population of the studies in which Psniff was measured was very small Wanke 
et al 8 found a Psniff of 7 5 (0 3) kPa in six normal subjects Koulouns et al 5 
measured a Psniff of 11 4 (0 7) kPa in ten normal subjects 
Sniff pressures performed with one instead of two open nostrils were higher in 
40 of the 42 subjects Pertuze et al 2 3 showed that the sum of separate 
flow-volume curves through the left and right nasal passages were similar to 
the total inspiratory nasal flow Unilateral occlusion did not lead to an immediate 
dilatation of the contralateral nasal airway Nasal inspiratory flow depends on 
the nasal resistance and changes proportionately to the degree of mucosal 
congestion 2 4 2 6 Therefore, force-velocity and force-length relationships, as 
discussed before, might be responsible for the pressure differences found A 
second explanation could be that the collapse of the nasal valve occurs at a 
lower transnasal pressure gradient when one nostril is used during a sniff 
manoeuvre 2 4 The assessment of inspiratory muscle strength by the sniff 
procedure could possibly improve by using one instead of two nostrils 
Activation, co-ordination and recruitment of diaphragm and other respiratory 
muscles are not maximal in the supine position 10 In the upright posture, there 
is generally more phasic and tonic activity in the scalene, sternocleidomastoid 
and parasternal intercostal muscles The diaphragm shows more phasic activ­
ity, while the abdominal oblique muscles show more tonic activity This results 
in an increased rib cage motion 2 7 2 8 Also, the compliance of the rib cage 
increases, and the compliance of the diaphragm-abdomen compartment de­
creases, in the upright position 2 9 All of these factors appear to compensate 
for the longer costal and crural segments of the diaphragm and the higher 
velocity of contraction in supine position in normal subjects 30, since the 
inspiratory mouth pressures measured supinely were significantly lower than 
those when sitting upright 
After 20-28 sniff manoeuvres, Psniff was significantly lower than Psniff at the 
beginning of the session, when a plateau had been reached "Fatigue", defined 
as a condition in which there is a loss in capacity for developing force resulting 
from muscle activity under load, which is reversible by rest 31, might be an 
explanation Although the pressure time index (PTi) was far below the fatigue 
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threshold (PTi 0 15) 3 2 considering the contraction time to be less than 500 ms 
and the pause being 10 s "fatigue" occurred The reasons for the "fatigue" 
found in this study remain unclear Measurements of motivation, relaxation rate 
3 3
 or power spectrum of the respiratory muscle electrogram 3 4 might yield some 
more insight Miller et al 7 stated, in their original study, that the manoeuvre 
was not tiring Their subjects performed approximately 16 sniffs Possibly the 
larger number of sniff manoeuvres in our study is responsible for the difference 
The time between the sniff manoeuvres was the same as in the study by Miller 
et al 7 In studies published later, the time between two sniffs was increased 
from two normal breaths to 10-45 s 6 8 Fiz et al 3 5 showed that chronic 
obstructive pulmonary disease (COPD) patients could make 20 subsequent 
static Plmax manoeuvres without decline in pressure They did not investigate 
when Plmax declined, so we do not know after how many static manoeuvres 
"fatigue" will appear 
From the data of this study we conclude that 1 Plmax is significantly higher 
than Psniff, 2 the agreement between Psniff and Plmax as well as the 
agreement between Psniff with one nostril open and Plmax is low, so that the 
two types of measurement are not interchangeable 3 Psniff performed with 
one open nostril is significantly higher than with two nostrils open, conse­
quently, nasal congestion will influence the measurement of Psniff, 4 both 
Plmax and Psniff in supine position are significantly lower than in sitting position 
and 5 a decline in Psniff occurs after 20-28 sniff manoeuvres, possibly due to 
some kind of "fatigue" 
When assessment of maximal inspiratory muscle strength is needed, it is 
important to realize that the results of respiratory muscle strength measure­
ments are influenced by the type of measurement, body position and the 
number of efforts 
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4.1 ABSTRACT 
Background Inspiratory muscle strength in patients with chronic obstructive 
pulmonary disease (COPD) can be affected by mechanical factors which 
influence the length of the diaphragm, and by non-mechanical factors The 
aims of the present study were to evaluate firstly the effects of body position 
on respiratory pressures and, secondly, to determine the relative contribution 
of age, body mass index (BMI), lung volumes, and arterial blood gas tensions 
to respiratory muscle strength 
Methods Thirty male patients with stable COPD (mean forced expiratory 
volume in one second (FEVi) 40 4% predicted) participated in the study 
Maximal inspiratory and expiratory mouth pressures (Plmax, PEmax) and 
maximal inspiratory transdiaphragmatic pressures (Pdi) in the sitting and 
supine position, lung function and arterial blood tensions were measured 
Results mean (SD) Plmax in the sitting position was higher than in the supine 
position (7 1 (2 3) kPa versus 6 4 (2 2) kPa respectively) In contrast, Pdi in the 
sitting position was lower than in the supine position (10 0 (3 5) kPa versus 
10 8 (3 7) kPa respectively) PEmax was higher in the sitting position, 9 3 (3 0) 
kPa than in the supine position 8 7 (2 8) kPa Significant correlations were found 
between inspiratory muscle strength on the one hand and lung function 
parameters, BMI and arterial blood gas tensions on the other 
Conclusions Inspiratory muscle strength in patients with COPD is influenced 
by mechanical factors (body position, lung volumes) and non-mechanical 
factors (BMI, FEVi and blood gases) Plmax and PEmax are lower in the supine 
position, while in contrast to healthy subjects, Pdi is higher in the supine 
position than in the sitting position 
4.2 INTRODUCTION 
Maximal inspiratory pressures (Plmax) in patients with chronic obstructive 
pulmonary disease (COPD) are frequently reported to be lower than in normal 
adults 1 6 In some studies however, taking hyperinflation into account, Plmax 
was similar or even increased in comparison with normal subjects 7"10 Pressure 
generation by the diaphragm is influenced by the length of the diaphragm 1112 
Theoretically it is possible to influence the length of the diaphragm in patients 
with COPD by changing position from sitting to supine The flattened dia-
phragm will then be displaced upwards by the abdominal contents, and will 
achieve a more advantageous position on the length-tension curve Higher 
transdiaphragmatic pressures (Pdi) would therefore be expected in the supine 
position This would be in contrast to healthy subjects in whom Pdi is lower in 
the supine position 13 
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Besides mechanical factors, non-mechanical factors such as age,1·3 height,3 
weight,3,14 sustained overload,15 hypoxaemia,16 and hypercapnia,17 may also 
influence respiratory pressures. In most studies the influences of these factors 
have been analysed separately. The purpose of the present study was, firstly, 
to evaluate the effects of body position on respiratory pressures, and, secondly, 
to determine the relative contribution of mechanical and non-mechanical factors 
to respiratory muscle strength in stable patients with COPD. 
4.3 METHODS 
Study design 
Respiratory muscle strength measurements, lung function tests, and blood gas 
analyses were performed in 30 patients with COPD. Informed consent was 
obtained from all subjects. The study was approved by the hospital ethical 
committee. 
Patients 
Thirty male patients with COPD, according to the criteria of the American 
Thoracic Society,18 participated in the study. Age, body measures, and lung 
function data are shown in Table 1. The patients were in a stable condition, 
Table 1 
Patient characteristics, lung function data and blood gas values (n=30) 
Age (yrs) 
Height (cm) 
Weight (kg) 
BMI (kg/m2) 
FEV, (%pred) 
FEV, (1) 
FIV, (1) 
FRC (%pred) 
mean (SD) 
60 7 (6 5) 
174 8 (6 9) 
74 0(10 8) 
24 2 (2.8) 
40.4 (19.0) 
1.3 (0.7) 
3.1 (0 8) 
132.4(29.3) 
RV (%pred) 
TLC (%pred) 
RV %TLC (%) 
FRC %TLC (%) 
KCO (%pred) 
Sa02 (%) 
Pa02 (kPa) 
PaC02 (kPa) 
mean (SD) 
146 7(37 1) 
1077(16 1) 
47 4 (9.1) 
63.3 (8.4) 
57.5 (29.1) 
94.0 (2.3) 
9 4 (1.1) 
5.7 (0 7) 
BMI body mass index, FEVi forced expiratory volume in one second, Я і Forced inspiratory volume in one second, 
FRC functional residual capacity, RV residual volume, TLC total lung capacity, KCO diffusion capacity standardised 
for effective alveolar volume, SaOi arterial oxygen saturation, РаОг partial arterial oxygen tension, PaCCh partial arte­
rial carbon dioxide tension 
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defined as no change in FEVi during the preceding three months Patients with 
other pulmonary diseases, a previous thoracotomy, diabetes mellitus, and 
neuromuscular disorders were excluded 
Measurements 
Pressure measurements 
Maximal inspiratory and expiratory mouth pressures (Plmax, PEmax) were 
measured with a device that was based on that one used by Black and Hyatt1 
A metal tube connected a plastic flanged mouthpiece with a wet spirometer 
(Pulmotest Godart, Bilthoven, the Netherlands) An occluding balloon within 
the tube could be inflated by the subjects themselves by squeezing a second 
external balloon A small leak (internal diameter 1 1 mm, length 40 mm) in the 
mouthpiece prevented buccal muscles from producing significant pressures 
and closing the glottis The pressure inside the mouthpiece was measured with 
a pressure transducer (Validyne DP103-32, Northndge, California, USA) 
Transdiaphragmatic pressure (Pdi) was measured with a flexible double lumen 
catheter (id of each lumen 1 1 mm)1920 inserted through the nose The 
catheter was positioned with the distal opening of the gastric lumen 58 cm from 
the nares and the proximal opening of the oesophageal lumen 38 cm from the 
nares The catheter was perfused with water at a constant flow of 99 ml/hour 
The pressure generated by the water flow was 1 2 kPa The proximal ends of 
the double lumen catheter were connected with two pressure transducers 
(Validyne DP15-32, range ± 40 kPa) The zero reference point was arbitrarily 
set as the pressure measured at functional residual capacity (FRC) Pdi was 
calculated by subtracting oesophageal pressure (Poes) from gastric pressure 
(Pga) Plmax, PEmax, Poes and Pga were displayed on a chart recorder (Kipp 
en Zonen BD 101, Delft, the Netherlands) Pressure measurements were 
performed in the sitting and supine position, with the subjects wearing a 
noseclip In either position the subjects maintained an identical posture and 
had appropriate support for their arms throughout the experiment Before each 
static inspiratory effort subjects inhaled to total lung capacity (TLC) and then 
exhaled to residual volume (RV), with visual feedback on the spirometer They 
then closed the tube by inflating the balloon and performed a maximal 
inspiratory effort Maximal inspiratory efforts were maintained for two seconds 
separated by at least 60 seconds between efforts 
PEmax was measured after inhaling to TLC, followed by inflating the balloon 
and performing a maximal static expiratory effort The inspiratory manoeuvre 
at RV and the expiratory manoeuvre at TLC were repeated until three repro-
ducible measurements had been made with a maximal variability of 10% 21 
The highest value was used for analysis For the sake of convenience, Plmax 
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and Poes were expressed as positive values At each measurement calibrations 
were made with a water manometer 
Predicted values for respiratory muscle strength were calculated according to 
Wilson et al ,3 because these authors also used a flanged mouthpiece 
Lung function 
Spirometrie tests were performed with a wet spirometer and by a closed circuit 
helium-dilution method (Pulmonet III, Sensormedics, Bilthoven, the Nether­
lands) Diffusion capacity (KCO) was measured by the single breath carbon 
monoxide method (Sensormedics 2450) Predicted spirometrie values were 
derived from ERS standards 2 2 
Blood gas values 
Arterial blood samples were taken in the semirecumbent position, at 9 o'clock 
am, after the patients had been lying down for at least 15 minutes The samples 
were measured with a Corning Ph 127 blood gas analyser 
Data analysis 
Data are presented as means (SD) To analyse the data statistically we per­
formed Spearman correlation tests and Wilcoxon signed rank tests Stepwise 
multiple regression analysis was used to assess the relative contributions of 
age, body mass index (BMI), FRC%TLC, FEVi, SaCte, and РаССЫо Plmax, Pdi, 
and PEmax For all analyses the SAS package (SAS Institute Ine , Сагу, North 
Carolina, USA) was used ρ values <0 05 were considered significant 
4.4 RESULTS 
Patients 
Thirty male patients with COPD were included in the study There was a wide 
variation of airway obstruction (FEVi ranged from 18 - 87 % predicted) and 
hyperinflation was modest (mean FRC 132 (29) % predicted) Four patients 
were hypoxaemic (PaÜ2< 8kPa) and one patient was hypercapnic (PaC02 
>6 5 kPa) 
Respiratory muscle force and effect of body position 
Sitting Plmax and PEmax were lower than predicted, Plmax being 89 1 (28 1) 
% predicted (7 1 (2 3) kPa) and PEmax was 74 1 (23 4) % predicted (9 3 (3 0) 
kPa) The low value for PEmax could be caused by the closing of the glottis 
when performing a PEmax manoeuvre, so, PEmax was also measured at the 
oesophageal level At this level the value was significantly higher than at the 
mouth (10 8 (2 9) kPa versus 9 3 (3 0) kPa (p< 0 01)) The lung volume 
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Figure 3 Poes/Pdi in sitting and supine position f > and < indicate mean values) 
(expressed as percentage of the predicted TLC) at which maximal inspiratory 
pressures in the sitting position were measured, was 60 8 (14 1) % The supine 
maximal inspiratory pressures were measured at a significantly higher lung 
volume (64 4 (15 3) % of TLC predicted (p< 0 001)) This happened despite 
patients being asked to expire to RV in both positions In the supine position 
the same end expiratory level was not reached by 24 of the 30 patients in 
comparison with the sitting position 
Pdi could not be measured in three patients because of their inability to swallow 
the double lumen catheter The mean value in the remaining 27 patients was 
10 0(3 5)kPa 
When changing position from sitting to supine, Plmax decreased by 0 7 (0 6) 
kPa (p< 0 0001) and PEmax decreased by 0 6 (1 2) kPa (p< 0 05) In contrast, 
Pdi increased by 0 9 (1 5) kPa (p< 0 01) (Fig 1) To determine whether the 
diaphragm is a better pressure generator in the supine position, the two 
components of Pdi (Pga and Poes) were studied They showed different 
responses to the change in body position Pga increased from 1 8 (1 4) kPa in 
the sitting position to 3 0 (2 1) kPa in the supine position (p< 0 0001) Poes 
decreased from 8 1 (2 8) kPa in the sitting position to 7 8 (2 6) kPa in the supine 
position, but this change did not reach significance (p = 0 24) The changes in 
Pga and Poes in relation to Pdi are shown in Figures 2 and 3 The mean 
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differences between the sitting and supine ratios Pga/Pdi and Poes/Pdi were 
0.11 (0.13) (p< 0.0001) and -0.11 (0.13) (p< 0.0001), respectively. In the sitting 
position the ratio Plmax/Poes was 0.07 (0.11) (p< 0.01) higher than in the 
supine position (Fig 4). 
Factors influencing respiratory muscle force 
Spearman correlation coefficients between maximal respiratory pressures on 
the one hand and age, BMI, lung function parameters and blood gas values 
on the other are shown in Table 2. The highest correlation coefficients were 
found between maximal inspiratory pressures and FRC%TLC (%) and arterial 
oxygen saturation (tension). PEmax was not correlated with any of these 
parameters and PEmax was only significantly correlated with Plmax and Pdi; 
both correlation coefficients were 0.60 (p< 0.001). 
Stepwise multiple regression analysis showed that Plmax (kPa) could be 
predicted from a combination of SaÜ2 and FRC%TLC: 
Plmax (kPa) = -17.8 - 0.12 Sa02 + 0.34 FRC%TLC (r2 = 0.44). 
Pdi (kPa) could be predicted only by БаОг: Pdi = -70.2 + 0.85 SaCte (r2 = 
0.33). PEmax (kPa) was predicted by age: PEmax = 20.1 - 0.18 Age (r2 = 
0.14). 
Table 3 shows the complete data with values of ρ and r2. 
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Table 2 
Spearman correlation coefficients between maximal respiratory pressures 
and age, BMI, lung function parameters and blood gas values 
Age (yrs) 
BMI (kg/mZ) 
FRC %TLC (%) 
RV %TLC (%) 
FEV, (%pred) 
FIV, (1) 
Sa0 2 (%) 
Pa0 2 (kPa) 
PaC02 (kPa) 
PImax 
(kPa) 
- 0 32 
0 30 
- 0 5 9 * * * 
- 0 4 8 * * 
0 4 9 * * 
0 4 8 * * 
0 6 2 * * * 
0 5 8 * * * 
- 0 4 1 * 
PImax 
(%pred) 
0 05 
0 39* 
- 0 6 1 * * * 
- 0 4 4 * * 
0 6 0 * * * 
0 5 1 * * 
0 5 5 * * 
0 5 1 * * 
- 0 27 
Pdi 
(kPa) 
-0 36 
0 34 
- 0 5 4 * * 
- 0 45* 
0 43* 
0 48* 
0 6 4 * * * 
0 6 7 * * * 
- 0 30 
PEmax 
(kPa) 
- 0 35 
006 
- 0 09 
- 0 05 
0 08 
0 25 
0 27 
0 30 
- 0 25 
PEmax 
(%pred) 
- 0 21 
0 06 
- 0 05 
000 
0 08 
0 23 
0 19 
0 24 
-015 
For definition ol abbreviations see footnote table I 'p<005'*p<001 *** ρ <0 001 
Table 3~l 
Stepwise multiply regression analyses, г , and ρ values 
to predict maximal respiratory pressures 
PImax (kPa) 
PImax (%pred) 
Pdi (kPa) 
PEmax 
PEmax (%pred) 
Step 
1 
2 
1 
1 
1 
-
Variable 
FRC%TLC 
Sa02 
FRC%TLC 
Sa02 
Age 
-
2 
r 
0 34 
0 43 
0 30 
0 33 
014 
-
Ρ 
0 001 
0 004 
0 002 
0 002 
0 004 
-
For definition ol abbreviations see footnote to table 1 
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4.5 DISCUSSION 
The purposes of this study were to evaluate the effects of body position on 
respiratory pressures and to determine the relative contribution of mechanical 
and non-mechanical factors to respiratory muscle strength in patients with 
COPD Firstly, we found that body position influences respiratory pressures 
Plmax and PEmax were higher in the sitting position than in the supine position, 
while Pdi, in contrast to healthy subjects, was higher in the supine position than 
in the sitting position (Fig 1) Secondly, mechanical and non-mechanical 
factors indeed contributed to respiratory muscle strength This was indicated 
by significant correlations between inspiratory muscle strength and static lung 
volumes (mechanical factors), and between inspiratory muscle strength and 
BMI, FEVi, Sa02 and РаСОг (non-mechanical factors) 
The diaphragm appeared to be a better pressure generator in the supine 
position in these patients with COPD In this position higher Pdi values were 
caused by an increase in the ratio Pga/Pdi combined with a decrease in the 
ratio Poes/Pdi (Figures 2 and 3) The difference between the ratio Plmax/Poes 
in the sitting and supine position was -0 07 (Fig 4), since Plmax decreased 
more than Poes in the supine position The reason why Poes did not decrease 
significantly in contrast to Plmax might be the elastic recoil pressure of the 
lungs which influences Plmax but not Poes The supine inspiratory pressures 
were measured at 64 4 (15 3) % of TLC predicted, while the sitting inspiratory 
pressures were measured at 60 8 (14 1) % of TLC predicted, although the 
patients were asked to expire as far as possible before they performed a 
maximal inspiratory manoeuvre in both positions At higher lung volumes the 
elastic recoil pressre of the lungs increases, and thus the difference between 
inspiratory mouth pressures and inspiratory oesophageal pressures will in­
crease 6 This is confirmed by the findings in the present study the mean 
difference between Plmax and Poes in the sitting position was 1 0 kPa, while 
the mean difference in the supine position was 1 4 kPa 
In healthy subjects, both Plmax and Pdi were lower in the supine position 13 
The effect of postural changes on maximal respiratory pressures in patients 
with COPD has not previously been described Swings in Pdi during tidal 
breathing in the supine position were significantly higher than in the sitting 
position 2 3 This is in line with the findings in the present study An explanation 
might be that in the supine position the abdominal contents displace the 
flattened diaphragm upwards, leading to a more favourable position on the 
length-tension curve However, the increased force generated by the dia­
phragm apparently cannot compensate for the decreased phasic and tonic 
activity of the scalene, sternocleidomastoid and parasternal-mtercostal mus­
cles and the decreased compliance of the rib cage in the supine position 2 4 2 5 
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This may explain why in our patients Plmax in the supine position was signifi­
cantly lower than Plmax in the sitting position 
Plmax values were lower than predicted (89 1 (28 1) %), but these pressures 
were measured at 60 8 (14 1 ) % predicted TLC Rochester26 suggested that the 
observed values of Plmax in patients with COPD should be compared with the 
values that normal subjects would achieve at similar lung volumes For normal 
subjects we expected 80-90% of the predicted Plmax at 60% TLC 6 2 7 This 
means that Plmax, after correction for lung volume, was not lower than in normal 
subjects, as was suggested in previous studies 7"10 Also, in a postmortem 
study, diaphragm dimensions of patients with and without COPD did not differ 
significantly 2Θ Plmax values in our patients [71 (2 3) kPa] were within the same 
range as Plmax values in patients with COPD described in previous studies (71 
(2 4) kPa,10 5 6 (2 5) kPa,4 6 0 (1 9) kPa,5 and 8 0 (2 7) kPa29) These different 
results may be explained by differences in patient characteristics The relation 
between Plmax and FEVi (%predicted) in these studies seems linear (Fig 5) 
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Figure 5 Correlation between Plmax and FEV1 in different studies 
Square 4 triangle 7 round 5 diamond 29 and star for the present study 
For Pdi no predicted values are available Mean Pdi in normal subjects varied 
from 9 1 kPa to 15 0 kPa and in patients with COPD from 3 7 kPa to 9 8 kPa 2 1 
We measured a mean Pdi of 10 0 (3 5) kPa The observed difference between 
healthy subjects and patients with COPD may be explained by a different 
position on the length-tension curve due to changes in lung volumes 1 2 3 0 3 2 
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This may explain the correlation between maximal inspiratory pressures and 
FRC and RV as percentages of TLC in the present study 
In previous studies the variability of PEmax in patients with COPD was larger 
than that of Plmax (20 6 (4 1) kPa,10 13 7 (4 8) kPa,4 13 8 (6 5) kPa,5 and 10 0 
kPa6), whereas in our study PEmax was 9 3 (3 0)) kPa PEmax in the present 
study was rather low in comparison to the other studies An explanation might 
be the closing of the glottis by some patients when performing a PEmax 
manoeuvre, because PEmax measured in the oesophagus was significantly 
higher than PEmax measured in the mouth (10 8 (2 9) kPa versus 9 3 (3 0) kPa, 
respectively (p< 0 01 )) Decramer et al 6 suggested that minor variations in the 
technique contributed to high variations in PEmax values Another explanation 
for the low PEmax values in the present study could be generalised muscle 
weakness This was probably not the case, since Plmax (%predicted) was less 
decreased than PEmax (%predicted) Plmax is influenced by hyperinflation and 
generalised muscle weakness, while PEmax is influenced by generalised 
muscle weakness alone4 Moreover, malnutrition may be responsible for lower 
PEmax values,33 but this was unlikely since BMI was within the normal range 
In view of these considerations it is most likely that the low PEmax values in 
the present study were due to the technique used 
Besides mechanical factors (body position, static lung volumes), non-me­
chanical factors may influence respiratory muscle strength Significant corre­
lation coefficients were found between inspiratory pressures and BMI, FEVi, 
Sa02, and РаСОг (Tabel 2) 
The effects of BMI on inspiratory pressures is known Undernourished patients 
with COPD have lower inspiratory muscle strength than well nourished pa­
tients 3 3 
The relation between FEVi and Plmax might suggest that the impaired muscle 
function results in lower FEVi values It is also possible, however, that a 
decrease in FEVi contributes to the impairment of inspiratory muscle function 
because of a sustained overload 15 Indeed, the diameters of type I and type II 
fibres of the diaphragm in normal subjects were significantly higher than in 
patients with COPD 3 4 Moreover, there was a linear relationship between FEVi 
and diaphragmatic fibre diameters in these patients 
Little is known about the consequences of chronic hypoxaemia on respiratory 
muscles, as is present in patients with chronic respiratory failure, or about the 
influence of respiratory muscle dysfunction on РаОг It has been suggested 
that impairment of the respiratory muscles causes microatelectasis resulting 
in a decrease of РаОг3 5 3 6 The consequences of acute hypoxaemia on 
respiratory muscles in normal persons have been investigated One study 
showed that the respiratory muscles failed more quickly during low oxygen 
breathing,16 but this was not confirmed in a later study 3 7 
zk 
Effects of body position, hyperinflation and blood gas tensions on maximal 
respiratory pressures in patients with chronic obstructive pulmonary disease 
Ζ 
A negative correlation between Plmax and РаСОг has been found in previous 
studies 4 · 1 7 3 8 Rochester et a l 4 showed a correlation of -0 66 in 18 patients with 
COPD with Plmax< 5 5 kPa Braun et al ^38 studied the correlation between 
Plmax and РаСОг in patients with proximal myopathies and found a correlation 
coefficient of -0 59 when respiratory muscle strength was less than 50% 
predicted Diaphragmatic contractility was reduced when end-tidal FCO2 was 
raised above 7 5% 17 
Multiple regression analysis was used to determine the relative contribution of 
influencing factors such as age, BMI, blood gas tensions and lung function to 
respiratory muscle strength (Tabel 3). Only low predictive values were obtained. 
This suggests that other individual features such as elastic recoil pressure of 
the respiratory system and physical fitness also influence maximal respiratory 
pressures. 
In conclusion, this study shows that respiratory pressures in patients with COPD 
are influenced by body position Plmax and PEmax are lower in the supine 
position, while in contrast to healthy subjects, Pdi is higher in the supine position 
than in the sitting position In addition, significant correlations have been found 
between maximal respiratory pressures and mechanical and non-mechanical 
factors, although the value of these factors in predicting maximal respiratory 
pressures is low 
4.6 REFERENCES 
1. Black LF, Hyatt RE Maximal respiratory pressures normal values and relationship to 
age and sex Am Rev Respir Dis 1969, 99 696-702 
2. Rochester DF, Arora NS, Braun NMT The respiratory muscles in chronic obstructive 
pulmonary disease (COPD) Bull Eur Physiopathol Respir 1979, 15 951-975 
3. Wilson SH, Cooke NT, Edwards RHT, Spiro SG Predicted normal values for maximal 
respiratory pressures in Caucasian adults and children Thorax 19Θ4, 39 535-538 
4. Rochester DF, Braun NMT Determinants of maximal inspiratory pressure in chronic 
obstructive pulmonary disease Am Rev Respir Dis 1985,132 42-47 
5. Morrison NJ, Richardson J, Dunn L, Pardy RL Respiratory muscle performance in 
normal elderly subjects and patients with COPD Chest 1989, 95 90-94 
6. Decramer M, Demedts M, Rochette F, Bildet L Maximal transrespiratory pressures in 
obstructive lung disease Bull Eur Physiopathol Respir 1980,16 479-490 
7. Rochester DF, Braun NMT, Arora NS Respiratory muscle strength in chronic obstruc­
tive pulmonary disease Am Rev Respir Dis 1979,199 151-154 
^ 
Effects of body position, hyperinflation and blood gas tensions on maximal 
respiratory pressures in patients with chronic obstructive pulmonary disease 
8. Newell SZ, McKenzie DKM, Gandevia SC Inspiratory and skeletal muscle strength 
and endurance and diaphragmatic activation in patients with chronic airflow limita­
tion Thorax 1989, 44 903-912 
9. Similowski T, Yan S, Gauthier AP, Macklem PT, Bellemare F Contractile properties 
of the human diaphragm during chronic hyperinflation N Engl J Med 1991, 
325 917-923 
10. Byrd RB, Hyatt RE Maximal respiratory pressures in chronic obstructive lung dis­
ease Am Rev Respir Dis 1968, 98 848-856 
11. Agostoni E, Rahn H Abdominal and thoracic pressures at different lung volumes 
J Appi Physiol 1960, 15 1087-1092 
12. Rahn H, Otis AB, Chadwick LE, Fenn WO The pressure-volume diagram of the tho­
rax and lung Am J Physiol 1946,146 161 -178 
13. Koulouns N, Mulvey DA, Laroche CM, Goldstone J, Moxham J, Green M The ef­
fect of posture and abdominal binding on respiratory pressures Eur Respir J 1989, 
2 961-965 
14. Arora NS, Rochester DF Effect of body weight and muscularity on human dia­
phragm muscle mass, thickness, and area J Appi Physiol 1982, 52 64-70 
15. Braun NMT, Rochester DF Respiratory muscle function in chronic obstructive pul­
monary disease (COPD) Am Rev Respir Dis 1977, 115 91 
16. Jardim J, Farkas G, Prefaut C, Thomas D, Macklem PT, Roussos С The failing in­
spiratory muscles under normoxic and hypoxic conditions Am Rev Respir Dis 
1981, 124 274-279 
17. Juan G, Calverley P, Talamo С, Schnader J, Roussos С Effect of carbon dioxide 
on diaphragmatic function in human beings N EnglJ Med 1984, 310 874-879 
18. American Thoracic Society Standards for the diagnosis and care of patients with 
chronic obstructive pulmonary disease (COPD) and asthma Am Rev Respir Dis 
1987,136 225-244 
19. Yaekashiwa M, Shiraishi K, Motomiya M Mechanical properties of the lung evalu­
ated with a balloonless tube at different depths of the esophagus Am Rev Respir 
Dis 1991, 143A347 
20. Yaekashiwa M, Nakagawa J, Shiraishi K, Isawa T, Motomiya M Improved tech­
nique for the measurement of intrapleural pressure using an air-filled esophageal 
tube Am Rev Respir Dis 1990, 141 A716 
2 1 . LaPorta D, Grassmo A Assessment of transdiaphragmatic pressure in humans 
J Appi Physiol 1985, 58 1469-1476 
Effects of body position, hyperinflation and blood gas tensions on maximal 
respiratory pressures In patients wfth chronic obstructive pulmonary disease 
22. QuanjerPhH Standardized lung function testing Ei/rflespwJ1993, 6 (suppl 16) 3-
120s 
23. Druz WS, Sharp JT Electrical and mechanical activity of the diaphragm accompany­
ing body position in severe chronic obstructive pulmonary disease Am Rev Respir 
Dis 1982, 125 275-2Θ0 
24. Druz WS, Sharp JT Activity of respiratory muscles in upright and recumbant hu­
mans JApp/Pnys/o/1981,51 1552-1561 
25. Estenne M, Yernault JC, Troyer de A Rib cage and diaphragm-abdomen compli­
ance in humans effects of age and posture J Appi Physiol 1985, 59 1842-1848 
26. Rochester DF Tests of respiratory muscle function Clin Chest Med 1988,2 249-
261 
27. Cook CD, Mead J, Orzalesi MM Static volume-pressure characteristics of the respi­
ratory system during maximal efforts J Appi Physiol 1964,19 1016-1022 
28. Arora NS, Rochester DF COPD and human diaphragm muscle dimensions Chest 
1987 91 719-724 
29. Fiz JA Montserrat JM Picado С Plaza V, Agusti Vidal A How many manoeuvres 
should be done to measure maximal inspiratory mouth pressure in patients with 
chronic airflow obstruction Thorax 1989, 44 419 421 
30. McCully KK, Faulkner JA Length-tension relationship of mammalian diaphragm 
muscles J Appi Physiol 1983, 54 1681-1686 
31. Smith J, Bellemare F Effect of lung volume on in vivo contraction characteristics of 
human diaphragm J Appi Physiol 1987, 62 1893-1900 
32. Rochester DF The diaphragm in COPD N EnglJ Med 1991, 325 961-962 
33. Arora NS, Rochester DF Respiratory muscle strength and maximal voluntary ventila­
tion in undernourished patients Am Rev Respir Dis 1982, 126 5-8 
34. Sanchez J, Derenne JP, Debesse B, Riquet M, Monod H Typology of the respira­
tory muscles in normal men and in patients with moderate chronic respiratory dis­
eases Bull Eur Physiopathol Respir 1982, 18 901-914 
35. Troyer de A, Borenstem S, Cordier R Analysis of lung volume restriction in patients 
with respiratory muscle weakness Thorax 1980, 35 603-610 
36. Gibson GJ, Pride NB, Davis JN, Loh CL Pulmonary mechanics in patients with res­
piratory muscle weakness Am Rev Respir Dis 1977,115 389-395 
Effects of body position, hyperinflation and blood gas tensions on maximal 
respiratory pressures In patients with chronic obstructive pulmonary disease 
37. Ameredes BT, Clanton TL Hyperoxia and moderate hypoxia fail to affect inspira­
tory muscle fatigue in humans J Appi Physiol 19 Э, 66 894-900 
38. Braun NMT, Arora NS, Rochester DF Respiratory muscle and pulmonary function 
in polymyositis and other proximal myopathies Thorax 1983, 38 616-623 

CHAPTER 5 
NOCTURNAL SATURATION AND RESPIRATORY 
MUSCLE FUNCTION IN PATIENTS WITH COPD 
Heijdra YF, Dekhuijzen PNR, Herwaarden ν CLA, Folgering, HThM. 
Thorax 1995; 50:610-612 
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5.1 ABSTRACT 
Background Nocturnal desaturations, mainly caused by hypoventilation, oc­
cur frequently in patients with chronic obstructive pulmonary disease (COPD) 
Daytime arterial oxygen and carbondioxide tensions (РаОг and РаСОг) ap­
pear to predict which patients will desaturate at night It is unknown if respiratory 
muscle strength, which may be decreased in these patients, plays an addi­
tional role 
Methods In 34 patients with COPD (mean (SD), forced expiratory volume in 
one second (FEVi)41 7 (19 9) %pred) polysomnography, maximal respiratory 
pressures, lung function, and arterial blood gas tensions were measured 
Results Significant correlations were found between the mean nocturnal 
arterial oxygen saturation and maximal inspiratory mouth pressure (r=0 65), 
maximal inspiratory transdiaphragmatic pressure (r=0 53), FEVi (r=0 61), 
transfer coefficient for carbon monoxide (KCO) (r=0 38), arterial oxygen satu­
ration (Sa02) (r=0 75) and partial arterial carbon dioxide tension (РаСОг) 
(r=-0 44) Multiple regression analysis showed that 75% of the variance in 
nocturnal Sa02 was explained by a combination of Sa02 (70%) and FEVi (5%) 
Conclusion Inspiratory muscle strength and nocturnal saturation data are 
correlated, but daytime Sa02 and FEVi remain the most important predictors 
of nocturnal saturation 
5.2 INTRODUCTION 
The main cause of arterial oxygen desaturations associated with rapid eye 
movement (REM) sleep is hypoventilation 1 This, in turn, is partly determined 
by decreased intercostal and accessory muscle activity due to a lowered motor 
command 2 The diaphragm has to compensate for the diminished activity of 
these muscles during REM sleep In patients with chronic obstructive pulmo­
nary disease (COPD) however, strength and endurance of the diaphragm may 
be affected by their unfavourable position on the length-tension curve due to 
hyperinflation 3 
Daytime arterial oxygen saturation and carbondioxide tension (ЭаОг and 
РаСОг) predict 65-75% of the variance in nocturnal saturation 4 5 It is unknown 
if respiratory muscle strength has an additional role 
The purpose of the present study was therefore to evaluate the relation between 
inspiratory muscle strength and nocturnal saturation in 34 stable patients with 
COPD In addition, the contribution of inspiratory muscle strength to the 
prediction of nocturnal saturation was investigated 
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5.3 METHODS 
Thirty four patients with stable COPD 6 (30 men, mean (SD) forced expiratory 
volume in one second (FEVi), 41 7 (19 9) % pred, were included in the study, 
which was approved by the hospital medical ethics committee Patients with an 
obstructive sleep apnoea/hypopnoea syndrome or an overlap syndrome were 
excluded 
Polysomnography was performed including arterial oygen saturation, heart 
rate, end tidal PCO2 (PetCO?), thoracic movements and electro-oculography 
(EOG) Oxygen saturation (ЭаОг) and heart rate were measured in a real time 
format by a pulse oximeter A desaturation was defined by a combination of the 
definition of Block et al 7 and Fletcher et al 8 as a decrease by more than 4% 
in oxygenation from the baseline saturation when awake for a period of five 
minutes or more РеЮОг was measured with a sampling capnograph by 
introducing a catheter into the nasopharyngeal cavity The baseline awake and 
asleep БаОг and РеЮОг were defined as the mean ЭаОг and РеЮОг during 
the first 15 minutes of the record and while asleep, respectively Since PetC02 
is not representative of arterial PCO2, increases in РеЮОг signals were only 
used qualitatively as indicators of hypoventilation9 in combination with satura­
tion and thoracic movement signals Thoracic movements were analysed by 
respiratory inductive plethysmography An EOG was measured with surface 
electrodes and used for visual scoring of wakefulness, non-REM and REM 
sleep, in combination with the other signals10 When rapid eye movements were 
present and desaturations occurred in absence of gross body movements it 
was even more likely that REM sleep was present11 
Static maximal inspiratory and expiratory mouth pressures (Plmax, PEmax) as 
well as static maximal inspiratory transdiaphragmatic pressure (Pdi), were 
measured as described previously 12 The inspiratory manoeuvre at residual 
volume (RV) and the expiratory manoeuvre at total lung capacity (TLC) were 
repeated until three reproducible measurements had been made with a maxi­
mal variability of 10% The highest values were used for analysis The inspiratory 
pressures were expressed as absolute values Predicted values for respiratory 
muscle strength were derived from Wilson et al 13 
Dafa analysis 
Data are presented as means (SD) Spearman correlation tests were per­
formed p-values < 0 05 being considered significant Stepwise multiple 
regression analysis was used to assess which parameters were independent 
predictors of the nocturnal and daytime saturation The significance level for 
retention in the model was 0 05 
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5.4 RESULTS 
The mean age of the patients was 61.4 (6.4) years. They had a wide variation 
of airway obstruction (FEVi 0.6 - 3.2 I, mean 41.7 (19.9) % pred). They were 
hyperinflated (functional residual capacity (FRC) 127.8 (31.2) %pred) and had 
a low gas transfer coefficient (KCO) 57.5(28.5) % pred. Four patients were 
hypoxemic (РаОг < 8.0 kPa) and two patients were hypoxemic and hypercap-
nic (РаСОг > 6.5 kPa). The mean РаОг and РаСОг were 9.3 (1.3) kPa and 
5.7 (0.7) kPa, respectively. 
All patients had at least one period of REM sleep and, in the whole group, 10.8 
(4.6) % of the recording time was spent in REM sleep. Of the 34 patients 16 
developed episodes with desaturations during the night. In these 16 patients 
the mean desaturation time and the mean REM sleep time were 40.6 (27.7) % 
and 11.6 (4.0) % of the total recording time, respectively. In these patients 64.0 
(35.2) % of the total REM sleep was spent desaturated. This represents 18.2 
% of the total desaturation time. The Polysomnographie data are shown in 
Table 1. 
Plmax, Pdi and PEmax were 6.9 (2.3) kPa (87.5 [27] % pred), 9.7 (3.6) kPa and 
8.9 (3 0) kPa (73.1 [22.2] % pred), respectively. In four patients Pdi was not 
measured because of inability to swallow the oesophageal catheter. 
Table 1 
Nocturnal measurements 
Sa0 2 b awake (%) 
Mean NSa02 (%) 
% time des (%) 
Lowest NSa02 (%) 
PetC02 b awake (kPa) 
PetC02 asleep (kPa) 
Time in bed (min) 
Time In NREM (min) 
Time in REM (min) 
93 5 (2 5) 
90 6 (4 5) 
19 1 (27 8) 
83 3(12 2) 
5 0 (0 7) 
5 5 (0 9) 
454 (48) 
249 (69) 
49 (21) 
SaÛ2 b awake baseline arterial oxygen saturation awake during the first 15 minutes of the record, mean WSaOj 
mean nocturnal arterial oxygen saturation, % time des percentage of recording time patients were desaturated, 
РеЮОг b awake End-tidal carbon dioxide tension baseline awake, РеЮОг asleep End-tidal carbon dioxide tension 
asleep, NREM Non rapid eye movement sleep, REM rapid eye movement sleep 
Data are expressed as means (SD) 
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The correlation coefficients between nocturnal saturation data and daytime 
characteristics are presented in Table 2 The highest correlation coefficient was 
found between daytime and nocturnal saturation 
The correlation between Plmax (% pred) and mean nocturnal arterial oxygen 
saturation (NSaCte) (%) is shown in Figure 1 There was a large overlap between 
patients, who did and did not desaturate 
Mean NSa02 (%) , 
100 
95 
90 
85 
80 
75 
70 
¿ 1 ι I ι I ι . ι I ι I ι I ι Ι ­
Ο 2 4 6 8 10 12 14 
Plmax 
Figure 1 Relation between maximal inspiratory mouth pressure 
(Plmax) (% pred) and mean nocturnal arterial oxygen saturation 
r=0 63 (p< 0001) 
Stepwise multiple regression analysis was used to evaluate the contribution of 
various parameters in the prediction of the mean nocturnal saturation The input 
variables were the daytime parameters shown in Table 2 Of the variance in 
mean nocturnal SaCte, 75% was explained by a combination of daytime ЭаОг 
(70%) and FEVi (5%) A similar analysis was performed to predict daytime SaCte 
with the variables Plmax (kPa), Pdi (kPa), FEVi (% pred), FRC (% pred) and 
KCO (% pred) Pdi was the only predictive variable (r2 = 0 33) 
/ L · 
r = 0 6 5 ( p < 0 0 0 1 ) 
• desaturator 
• non-desaturalor 
Nocturnal saturation and respiratory muscle function In patients with COPD 
5.5 DISCUSSION 
This study shows that maximal inspiratory muscle strength and nocturnal 
saturation data are significantly correlated in patients with COPD. However, 
daytime Sa02 and FEVi remain the most important predictors of nocturnal 
saturation. 
An important cause of hypoventilation during REM sleep is diminished respi­
ratory activity of the intercostal and accessory muscles14 which increases the 
workload of the diaphragm. However, strength and endurance of the dia­
phragm in patients with COPD may be affected by their unfavourable position 
on the length-tension curve due to hyperinflation 3. It was therefore hypothe­
sised that a relation may exist between nocturnal arterial oxygen saturation and 
maximal inspiratory muscle strength, and a significant correlation was indeed 
shown between these two parameters (Fig 1 ). However, if patients were divided 
Table 2 
Spearman's correlation coefficients between daytime 
characteristics and nocturnal saturation data 
Daytime 
parameters 
Plmax (kPa) 
Pdi (kPa) 
SaOj (%) 
PaC02 (kPa) 
FEV1 (%pred) 
KCO (% pred) 
mean 
NSaOj (%) 
0 6 5 * * * 
0.53** 
0 7 5 * * * 
- 0 4 4 * * 
0 6 1 * * * 
0 39* 
Lowest 
NSa02 (%) 
0 6 0 * * * 
0 4 7 * * 
0 6 4 * * * 
-0 4 5 * * 
0 5 3 * * 
0 36 
%time 
des (%) 
-0 6 4 * * * 
-0 6 0 * * * 
- 0 6 7 * * * 
0 4 7 * * 
- 0 5 8 * * * 
- 0 34* 
Plmax static maximal inspiiatoiy mouth pressure, Pdi static maximal inspiiatory transdiaphragmatic 
pressure, SaOi arterial oxygen saturation, РаСОг partial arterial carbon dioxide tension; FEV ι torced expiratory 
volume in one second; KCO carbon monoxide transler coefficient, mean NSaOs mean nocturnal arterial oxygen 
saturation, lowest NSaOî lowest aiterei oxygen saturation, % des time percentage of recording time patients were 
desalurated *p < 005, **p < 007, * " p <0001 
into those who desaturated and those who did not, a considerable overlap was 
seen between the two groups. Plmax and Pdi appear to have a low predictive 
value, and this was confirmed by multiple regression analysis. Daytime SaÛ2 
and FEVi were the only independent predictors and explained 75 % of the 
A. 
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variance in the mean nocturnal saturation However, Pdi was the only predictive 
variable for daytime SaCte so, an indirect effect on nocturnal saturation via 
daytime SaCte is also possible The finding that FEVi was one of the inde-
pendent predictors in contrast to other studies 1516, may be explained by the 
wide range of FEVi values (0 6 - 3 21) in our patients 
The significance of daytime SaÜ2 in predicting the nocturnal saturation has 
been described previously Bradley et al 4 showed that daytime ЭаОг and 
РаСОг explained 68% of the nocturnal saturation in patients with COPD In 
another study a high correlation was found between daytime and nocturnal 
Sa02 in 97 patients with COPD5 
The definition of a desaturation as a decrease of more than 4 % in БаОг lasting 
at least five minutes was derived from the study of Block et al 7 combined with 
the study of Fletcher et al 8 who defined a nocturnal desaturation as a fall below 
90% lasting at least five minutes or more This latter study described desatura-
tions in patients with COPD in whom, in general, a serious desaturation lasted 
longer than five minutes in contrast to patients with an obstructive sleep apnoea 
syndrome in whom clinically important desaturations can last as little as 10 
seconds In addition, desaturations caused by movement usually last less than 
five minutes 
The patients in this study spent a long time awake This is probably due to the 
long recording time, defined as the total time patients spent in bed attached to 
the Polysomnographie apparatus, because the time spent in REM and non-
REM sleep was comparable to other sleep studies performed in patients with 
COPD 5 8 1 1 1 6 1 7 When the total recording time and the time patients were 
awake in our study were compared with the study of Gothe et al 17 similar results 
were found The total recording time and the time spent awake were 454 (48) 
minutes versus 449 (80) and 156 (58) minutes versus 188 (85) minutes in our 
study and that of Gothe et al, respectively 
Little is known about the impact of an experimental situation on sleep stage 
variability, Sa02, and breathing pattern in patients with COPD Two studies have 
shown that mean and lowest ЭаОг and the breathing pattern did not differ 
during two nights 1 7 1 θ Based on these data we presume that the outcome of 
the present study was not influenced by studying patients for only one night 
In conclusion, this study shows significant correlations between maximal inspi­
ratory muscle strength and nocturnal saturation data in patients with COPD 
However, 75% of the variability in mean nocturnal Sa02 was explained by 
daytime SaÛ2 and FEVi 
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6.1 ABSTRACT 
Background Acute exacerbations in patients with COPD may cause respira­
tory failure Changes in ventilation-perfusion ratio and in alveolar ventilation are 
the major causes of hypoxemia The purpose of this study was to investigate 
if respiratory muscle strength is decreased during an acute exacerbation and 
if this contributes to daytime and nocturnal hypoxemia 
Methods In eleven patients with an acute exacerbation of COPD, we measured 
maximal inspiratory mouth pressure (Plmax), maximal inspiratory transdia­
phragmatic pressure (Pdi), nocturnal saturation, lung function and arterial 
blood gases on the first and second day after admission to hospital, and after 
2 and 12 weeks 
Results Plmax (means [SD]) increased from 6 2 (1 5) after admission to 7 0 
(1 7) kPa after two weeks No further change was observed the next 10 weeks 
(7 1 [2 0] kPa) Pdi did not change between week 2 and 12 either (8 2 [3 1] 
and 7 9 [2 7] kPa, respectively) РаОг increased significantly from day 1 to day 
2 and week 2, while no changes were noticed after 12 weeks (values 7 2 [1 3], 
8 0 [1 5], 8 6 [1 3] and 8 8 [1 5], respectively) РаСОг did not change during 
the whole study period The mean nocturnal saturation improved from 82 4 
(8 0) to 90 2 (3 7) % between the first night and 2 weeks after admission No 
further change was observed No correlations were found between the change 
in daytime and nocturnal saturation and the change in Plmax 
Conclusion Plmax is significantly lower during an acute exacerbation, but this 
does not contribute to the lowered daytime and nocturnal saturation 
6.2 INTRODUCTION 
Acute exacerbations of patients with moderate to severe COPD may cause 
respiratory failure Intrapulmonary factors such as venous admixture, physi­
ological dead space ventilation and diffusion limitation to O2 as well as 
extrapulmonary factors like alveolar ventilation, inspired PO2, cardiac output 
and O2 consumption determine РаОг The three intrapulmonary factors and 
the alveolar ventilation are the four major mechanisms of hypoxemia 1 
For adequate ventilation, the working capacity of the respiratory muscles has 
to exceed the load During an exacerbation, the increased bronchial obstruc­
tion puts a higher work load on the respiratory muscles However, in patients 
with COPD maximal inspiratory muscle strength and endurance is often 
decreased because of the unfavourable position of the diaphragm on the 
length-tension curve due to hyperinflation, and by other factors such as 
hypoxemia, hypercapnia and the use of corticosteroids 2~5 During an exacer­
bation all these factors may impair the respiratory muscle function even more 
Acute exacerbations In patients with COPD, does 
decreased respiratory muscle strenght contribute to hypoxemia? 
Such an impaired muscle function possibly contributes to the respiratory failure 
during an acute exacerbation 
Therefore, the purposes of this study were firstly to investigate if Plmax is lower 
during an acute exacerbation, and secondly to study if a decreased Plmax 
during an exacerbation contributes to a decreased arterial oxygen saturation 
during day and night in patients with moderate to severe COPD 
6.3 METHODS 
Study design 
Eleven patients (1F) with an acute exacerbation of their COPD resulting in 
hospital admission were included The indications for hospitalisation according 
to the definition by the American Thoracic Society are 'an acute exacerbation 
of symptoms such as increased dyspnoea, cough, and sputum production or 
an acute respiratory failure characterized by respiratory distress, hypercapnia 
or worsening hypoxemia' 6 They were 64 4 (5 6) (mean [SD]) years old, had 
34 9 (12 0) pack years and a body mass index of 23 6 (1 7) kg/m2 Patients with 
congestive heart failure, other pulmonary diseases, a previous thoracotomy, 
diabetes mellitus, neuromuscular disorders and an obstructive sleep ap-
noea/hypopnoea syndrome were excluded 
Static maximal inspiratory and expiratory mouth pressures, static maximal 
inspiratory transdiaphragmatic pressure, nocturnal measurements, lung func-
tion tests and blood gas analyses were performed at intervals described in table 
1 Informed consent was obtained from all patients The study was approved 
by the hospital ethical committee 
Table 1 
Measurements 
Measurements 
Plmax, PEmax 
Pdi 
Nocturnal saturation 
Extended nocturnal recording 
Lung function 
Blood gas analysis 
first 
day 
X 
second 
day 
X 
X 
X 
first 
night 
X 
2 
weeks 
X 
X 
X 
X 
X 
12 
weeks 
X 
X 
X 
X 
X 
Plmax maximal inspiratory mouth pressure PEmax maximal 
expiratory mouth pressure Pdi maximal inspiratory transdiaphragmatic pressure 
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Measurements 
Respiratory pressure measurements 
Static maximal inspiratory and expiratory mouth pressures (Plmax, PEmax) as 
well as static maximal inspiratory transdiaphragmatic pressures (Pdi) were 
measured as described previously 4 Transdiaphragmatic pressures were not 
measured in the acute phase of an exacerbation Besides the maximal inspi­
ratory pressures measured at residual volume (RV), six maximal inspiratory 
manoeuvres were performed at different levels between total lung capacity 
(TLC) and RV Subsequently, the patients inhaled to TLC and then exhaled to 
different levels between TLC and RV It was possible to measure the level at 
which the manoeuvre was performed, because the patients were connected 
to a wet spirometer during the manoeuvres A curve was constructed in which 
the maximal inspiratory pressures at the different lung volumes were plotted 
against these volumes, expressed as percentage of predicted TLC By making 
curves on day 2 and after week 2 and week 12, the differences in RV which 
could develop during the recovery of an exacerbation could be corrected for. 
The maximal inspiratory pressures at the highest RV level measured were 
compared For example, when on day 2 RV was 70% of predicted TLC, after 
2 weeks 60% and after 12 weeks 50%, Plmax at 70% of predicted TLC was 
compared and called maximal standardised inspiratory mouth pressure 
(Plmax.std) 
Pressure measurements were performed in the sitting position, with the sub­
jects wearing a noseclip Maximal efforts, which were performed at intervals of 
at least 60 seconds were maintained for 2 seconds PEmax (from TLC) and 
Plmax and Pdi (from RV) were repeated until 3 reproducible measurements 
had been made with a maximal variability of 10% 7 Predicted values for 
respiratory muscle strength were calculated according to Wilson et al. 8 
Nocturnal measurements 
The first night after admission to hospital the arterial oxygen saturation and 
heart rate were measured with a pulse-oxymeter in a real-time format (Oxyshut-
tle, Sensor Medics, Anaheim, California) The data were stored and digitized 
Ten patients received oxygen by means of a nasal catheter because of a low 
РаОг To measure the saturation without oxygen, the oxygen was stopped two 
times during 30 minutes, when the patient was asleep. 
After 2 and 12 weeks nocturnal arterial oxygen saturation, heart rate, thoracic 
movements, electro-oculogram (EOG) and end-tidal PCO2 (PetCCte) were 
measured During the night none of the patients received oxygen anymore 
Oxygen saturation and heart rate were measured as described above The 
morning after recording, the saturation data were analysed using a computer 
programme providing mean nocturnal saturation (ЫЭаОг), standard deviation 
z ^ 
¿eV 
Acute exacerbations in patients with COPD, does 
decreased respiratory muscle strengM contribute to hypoxemia 
and a histogram of the distribution of % SaCte-values The baseline SaCte awake 
was defined as the mean saturation the first 15 minutes of the record, when the 
patient was awake and lying flat9 A desaturation was defined by combining 
the definition of a desaturation in the study of Block et al 1 0 and that in the study 
of Fletcher et al 11 as a decrease by more than 4% in oxygenation from the 
baseline saturation awake for a period of 5 minutes or more 
Thoracic movements were analysed by means of respiratory inductive plethys­
mography (Vitalog, Bear Island, California) Which was used as a qualitative 
indicator of respiratory activity 12 
In combination with the other signals, the EOG was used for visual scoring of 
wakefulness, non-REM and REM sleep 12 When rapid eye movements and 
desaturations were present at the same time, it was even more likely that REM 
sleep was present13 
The РеЮОг was measured with a sampling capnograph (Mijnhart Capnolyser, 
Bilthoven, The Netherlands) by introducing a catheter in the nasopharyngeal 
cavity Since PetCCte is not representative of the arterial carbon dioxide tension, 
changes in this parameter were only used as a qualitative indicator of hypoven­
tilation in combination with the signals of saturation and thoracic movements 
14 
The St Mary's hospital sleep questionnaire was used for assessing the quality 
of sleep in the preceding night15 
Lung function 
Spirometrie tests were performed with a wet spirometer and by a closed circuit 
helium dilution method (Pulmonet III, Sensormedics, Bilthoven, the Nether­
lands) Diffusion capacity (KCO) was measured by a single breath-holding 
monoxide method (Sensormedics 2450) Predicted spirometrie values were 
derived from ERS standards 16 
Blood gas values 
Arterial blood gas samples were taken in semirecumbent position at 09 00 am, 
after the patients had been lying down for at least 15 minutes (Corning Ph 127) 
Dead space ventilation and venous admixture were calculated by the Bohr 
equation, alveolar air equation and the venous admixture equation, respectively 
17
, assuming СаОг - С Ог = 5ml / 100ml and R = 0 8 
Statistical analysis 
Data are presented as means (SD) To analyse the data statistically the 
Wilcoxon signed rank test and Spearman correlation test were performed P-
values< 0 05 were considered significant For all analyses the SAS package 
(SAS Institute Ine, Cary, North Carolina) was used 
•л± 
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6.4 RESULTS 
Patients 
Eleven patients with COPD and an acute exacerbation were included in the 
study. The last FEVi measured in a stable period before admission ranged 
from 21-52% predicted (mean [SD] 33.5 [12.6]), and was measured between 
3 weeks and 24 months before admission (9.8 [3.0] months). 
On admission seven of the eleven patients were hypoxemic (РаОг< 8 kPa) 
and three patients were hypercapnic (РаСОг >6.5 kPa). Eight patients had 
positive sputum cultures. The other three patients already received antibiotics 
and no infectious agent was found. The chest X-rays did not reveal signs of 
pneumonia or cardiac failure. The patients were treated with oxygen and 
antibiotics if indicated, inhaled beta-agonists, inhaled anti-cholinergic drugs, 
intravenous theophyllines and D-adreson F (50 mg/24 h). 
Two patients could not be studied after 12 weeks because they had become 
oxygen-dependent. 
Table 2 
Lung function parameters during recovery after an exacerbation 
Parameter 
TLC (%pred) 
RV (%pred) 
FRC (%pred) 
FEV, (%pred) 
KCO (%pred) 
day 2 
n=11 
105 4(16 8) 
167 2(35 7) 
147 8(28 6) 
27 9 (9 4) 
2 weeks 
n=11 
105 5(14 1) 
156 0(32 2)* 
142.2 (25 7)+ 
30 9 (11 6) 
49.3(18.4) 
12 weeks 
n=9 
106.4(15 3) 
150 1 (34 2) 
141 1 (29 7) 
31 4(12 5) 
48.5(18 8) 
71C total lung capacity, RV residual volume, FRC functional residual capacity, FEVi forced expiratory 
volume in 1 second, KCO diffusion capacity 
Data are expressed as means (SD) 
* ρ < 0 05, + p = 0 06 compared to day 2 
The effects of an exacerbation on static and dynamic lung function parameters 
One day after admission to hospital, patients were significantly more hyperin-
flated than 2 weeks later. No further improvement was seen during the next ten 
weeks (Table 2). The FEVi did not change significantly during the recovery of 
an exacerbation. However, when comparing the FEVi on admission with the 
^ V 
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last FEVi measured in a stable period before admission, a significant decrease 
of the FEVi on admission was observed (Fig 1) 
FEV, (% pred) 
50 
40 
30 -
20 -
10 
p<001 
before day 2 2 weeks 12 weeks 
admission 
Figure 1 FEVi before and alter the exacerbation 
FEVi forced expiratory volume in 1 second 
The effects of an exacerbation on arterial blood gases, dead space ventilation 
and venous admixture 
The effects of an exacerbation on these parameters are shown in Table 3 SaÛ2 
and РаОг improved significantly between day 1 and 2 SaÛ2 did not improve 
significantly any more after day 2 (p=0 06) РаОг increased by 0 6 (0 7) kPa 
(p< 0 05) between day 2 and 14 and did not increase any further The venous 
admixture decreased by 5 2 (7 4) % (p < 0 05) between day 1 and 2 After that, 
no significant change was noticed РаСОг and dead space ventilation did not 
change during the whole study period 
The effects of an exacerbation on nocturnal measurements 
The mean nocturnal saturation during the 60 minutes without oxygen (10 
patients) or the whole night without oxygen (1 patient) during the first night was 
compared to the mean nocturnal saturation during the whole night after 2 and 
12 weeks In contrast to the daytime saturation, the mean nocturnal saturation 
improved by 7 7 (5 4) % (p< 0 001) between the recording during the first night 
and that after 2 weeks After that it remained stable (Table 4) The same was 
the case for the lowest nocturnal saturation (Tabel 4) 
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Table 3 
Blood gas values, dead space ventilation 
and venous admixture during the exacerbation 
Ph 
SaOj (%) 
Pa02 (kPa) 
PaC02 (kPa) 
Vd/Vt (%) 
Venous 
admixture (%) 
day 1 
n=11 
7 42 (0 04) 
Θ7 4 (6 4) 
7 2(13) 
6 0 (1 4) 
56 8 (9 5) 
25 9 
day 2 
n=11 
7 43 (0 03) 
89 6(6 3)* 
8 0(1 5 ) * * 
6 0 (1 2) 
54 7 (7 5) 
20 6 
2 weeks 
n=11 
7 43 (0 02) 
92 4(2 7 ) * * * $ 
8 6(1 1 ) * * * # 
5 9 (0 9) 
54 8 (8 4) 
164** 
12 weeks 
n=9 
7 42 (0 03) 
91 9(4 3)* 
8 8(1 5 ) * * 
5 8(1 1) 
53.1 (11 3) 
18 8* 
Sa02 artera/ oxygen saturation, РаОг partial arterial oxygen pressure, 
РаСОг partial arterial carbon dioxide pressure, VdM dead space ventilation 
Data are expressed as means (SD) 
* p <0 05, "p<001, * * * p < 0 001 compared to day I 
* p< 005. *p=0 06 compared to day 2 
The percentage of time patients were desaturated was only analysed 2 and 12 
weeks after the onset of the exacerbation, because 10 out of 11 patients were 
treated with oxygen during the first night. No significant difference was ob­
served (Table 4). Time spent in non-REM and REM stage did not differ between 
week 2 and 12. The number of hours asleep as assessed by the St Mary's 
hospital sleep scale did not change between the different nights (Table 4). 
The effect of an exacerbation on respiratory muscle strength 
Plmax as well as PEmax improved significantly between day 2 and 14, from 
82.2 (23.1) to 92.9 (26.4) % pred (p < 0.05) and from 77.4 (20.5) to 91.4 (23.0) 
% pred (p < 0.01), respectively. No further increase was noticed after this 
period (Figure 2). However, when the hyperinflation was corrected for in the 
acute phase of an exacerbation, no differences in maximal inspiratory pres­
sures were observed any more. Plmax.std measured at 73.4 (12.3) % predicted 
TLC was 5.5 (1.9), 5.4 (1.2) and 5.8 (1.6) kPa, respectively. Pdi was measured 
in 9 of the11 patients, because two patients could not swallow the catheter. 
Pdi did not change between week 2 and 12 either (Figure 2). 
^ V 
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Table 4 
Nocturnal measurements 
mean NSa02 (%) 
lowest NSa02 (%) 
% time des (%) 
Time in bed (mm) 
REM sleep (mm) 
Non-REM sleep (mm) 
St Mary's Hospital 
sleep scale (hours) 
night 1 
n=11 
82 4 (Θ 0)® 
74 5 
454 (55) 
5 1 (1 1) 
2 weeks 
n=11 
90 2 (3 7 ) * * * 
82 5 (9 4) 
15 1 (20 1) 
464 (35) 
38 (13) 
290 (55) 
4 9 (1 8) 
12 weeks 
n=9 
89 5(5 3)** 
79 8(17 0) 
18 2(27 6) 
453 (42) 
37(13) 
284 (59) 
5 2 (1 6) 
MednNSa02 mean nocturnal saturation lowest NSa02 lowest nocturnal saturation 
% time des percentage of time patients were 
desaturated REM sleep rapid eye movement sleep non REM sleep non rapid eye movement sleep 
Data are expressed as means (SD) 
*'p <001 "*p <0001 compared to night 1 
® mean saturation of two episodes of 30 minutes without oxygen in 10 patients 
anda registration of one whole night without oxygen in 1 patient 
Correlations between the change in daytime and nocturnal saturation and venous 
admixture, dead space ventilation, Plmax and FEVi 
The change in daytime and nocturnal saturation was only correlated with the 
change in venous admixture The decrease in venous admixture was correlated 
with an improvement in daytime and nocturnal saturation (Table 5) No signifi­
cant correlation was found between the change in Plmax and the nocturnal and 
daytime saturation 
6.5 DISCUSSION 
The present study shows that Plmax is significantly lower during an acute 
exacerbation This decrease is mainly due to hyperinflation and does not 
contribute to a lower arterial oxygen saturation during the day and night in 
patients with moderate to severe COPD 
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ш 
day 2 2 weeks 12 weeks 
Figure 2 Maximal respiratory muscle strength during and alter an exacerbation 
Plmax maximal inspiratory mouth pressure, PEmax maximal expiratory mouth pressure, Plmax,std maximal 
standardised msßiatory mouth pressure, Pdi maximal inspiratory transdiaphragmatic pressure 
Data are expressed as means (SD) 
* p < 0 0 5 , * * p <0 01 compared to day 2 
The increase in Plmax occurred between day 2 and 14 (Fig 2). After two weeks 
no further improvement was observed. However, when Plmax values corrected 
for hyperinflation were compared (Plmax,std) no differences were seen. This 
Table 5 
Spearman correlation coeffk 
day and night saturation and 
δ daytime parameters
 d a y ,.,4 
Venous admixture (%) 
Vd/Vt (%) 
Plmax (kPa) 
FEV, (1) 
;ients between 
other daytime parameters 
8meanNSa0 2 n l g h t ,. 1 4 (%) 
- 0 7 2 * * 
- 0 01 
- 0 08 
015 
5SaO 2 i d a y 0 . 1 4 (%) 
-0 9 4 * * * 
- 0 001 
0 39 
- 0 05 
Vd/Vt dead space, Plmax maximal inspiratory mouth pressure, 
FEVi forced expiratory volume in 1 second 
"p<001, "'p<0001 
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indicates that the decrease in RV between day 2 and 14 is responsible for the 
improvement in Plmax values, because of a decrease in the mechanical 
disadvantage 
O'Neill and McCarthy 18 also found lower Plmax and PEmax values on day 1 
compared to day 5 in 40 patients with COPD and an exacerbation These 
authors speculated that theophylline or the improvement in arterial blood gas 
values or both could be responsible for this effect The effects of theophylline 
on respiratory muscle strength are still controversial 19, but in our study this 
could not have caused the difference between Plmax on day 2 and after week 
2, because our patients used this medication throughout this period We did 
not find a correlation between the change in daytime or nocturnal saturation 
and the change in Plmax So, the improved oxygenation cannot be an expla-
nation either for the higher Plmax values after 2 weeks and vice versa In the 
study of O'Neil et a l1 8 RV also decreased by 25% between day 1 and 5, but 
this difference did not reach significance Nevertheless, these findings support 
the concept of decreasing hyperinflation as the cause of the improved respira-
tory muscle strength during the recovery of an exacerbation 
Severe obstruction may cause a sustained overload on the respiratory muscles 
and may contribute to a decrease in Plmax and PEmax 20 This is not likely to 
be the explanation for the decreased Plmax and PEmax values in the present 
study either, because the FEVi did not change throughout the study period 
(Figi) 
PEmax improved by 1 7 (1 3) kPa between day 2 and 14 The mechanism of 
this increase is not clear, since the expiratory muscles are not influenced by 
mechanical disadvantages It is not likely to be a sign of general muscle 
weakness In that case we would have expected Plmax % predicted to be lower 
than PEmax % predicted, since Plmax would have been affected by both 
hyperinflation and by general weakness This was not the case Possibly the 
lower PEmax is caused by increasing dyspnoea or by a form of 'fatigue', 
because we always measured PEmax after Plmax 
Our hypothesis that a decreased Plmax could have been responsible for the 
lower daytime and nocturnal saturation, has to be rejected No correlation was 
found between the change in Plmax and the change in saturation during the 
day and night The only variable that correlated with the daytime and nocturnal 
saturation was the venous admixture This correlation is not surprising, because 
the venous admixture was calculated by using daytime arterial blood gas 
values Calculating venous admixture without a pulmonary artery catheter has 
disadvantages, because during an exacerbation the respiratory exchange ratio 
as well as the arteno-venous difference in oxygen concentration may be 
different from normal resting values Another factor indicating that ventilatory 
pump failure did not cause hypoxemia in this group of patients, was the 
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unchanged PaCCte If a pump failure had been present, an increased РаСОг 
would have been expected 2 1 It might be speculated that a correlation between 
inspiratory muscle strength and arterial blood gases or nocturnal saturation 
might be found in patients with acute hypercapnic respiratory failure 
During the first night no full nocturnal recording of РеЮОг, EOG and thoracic 
movements could be performed and in ten patients the nocturnal saturation 
without oxygen was recorded during only one hour The remaining patient did 
not receive oxygen and could be analysed during the whole night The mean 
nocturnal saturation and the lowest nocturnal saturation might have been 
lower, if a recording would had been performed during the whole night, since 
there was a chance that we measured during non-REM sleep, whereas 
desaturations are usually most severe during REM sleep 1 3 Electroencepha­
lography was not performed in this study, so it was not possible to obtain 
clinical sleep staging However, eye movements taken from the EOG are 
sufficiently characteristic to allow visual scoring of wakefulness, REM and 
non-REM sleep 12 Between week 2 and 12 there was no difference in time 
spent in REM and non-REM stage 
In conclusion, this study shows that Plmax is decreased during an acute 
exacerbation due to increased hyperinflation, but this decrease in Plmax does 
not contribute to the lower arterial oxygen saturation during the day and night 
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Nocturnal saturation Improves by target-flow 
Inspiratory muscle training In patients with COPD 
7.1 ABSTRACT 
Nocturnal desaturations during REM sleep, caused by non-obstructive hy-
poventilation, occur frequently in patients with COPD This is partly caused by 
decreased activity of the intercostal and accessory muscles due to a lower 
motor command The diaphragm has to compensate for the diminished activity 
of these muscles during REM sleep However, in patients with COPD strength 
and endurance of the diaphragm may be affected by its unfavourable position 
on the length-tension curve because of hyperinflation The aim of this study 
was to establish the causal relationship between respiratory muscle function 
and nocturnal saturation in patients with COPD We hypothesised that target-
flow inspiratory muscle training (TF-IMT) would improve nocturnal saturation 
In 20 patients with stable COPD (FEVi 35 5 [14 1] % pred) and a mean 
nocturnal saturation below 92% we measured Plmax, Pdi, maximal sustainable 
inspiratory pressure (SIPmax), endurance time and nocturnal saturation in 
weeks 0, 4 and 10 During these ten weeks 10 patients underwent TF-IMT at 
60% of Plmax and 10 control patients received sham TF-IMT at 10% of Plmax 
Plmax, Pdi, SIPmax and the endurance time as well as the nocturnal saturation 
improved significantly in the 60% training group (by 3 0(15) kPa, 3 4(19) kPa, 
1 5 (1 4) kPa, 189 (149) s and 1 9 (2 2) %, respectively), where as no changes 
occurred in the sham training group Also, significant correlations were ob-
served between the change in Pdi, SIPmax and endurance time on the one 
hand and the change in nocturnal saturation on the other We conclude that 
TF-IMT improves the nocturnal saturation in patients with severe COPD by 
increasing respiratory muscle strength and endurance 
7.2 INTRODUCTION 
Many patients with severe COPD have low arterial oxygen saturation during 
the night1 2 The most important reason for nocturnal desaturations in these 
patients is hypoventilation 3 The most pronounced falls in saturation occur 
during REM sleep 2, because in this sleep stage skeletal postural muscle tone 
and the activity of intercostal and accessory respiratory muscles are decreased 
4 5
 This is caused by supraspinal inhibition of gamma motorneurons, and 
presynaptic inhibition of afferent terminals of muscle spindles The diaphragm 
escapes from reduction of activation during REM sleep, because it is almost 
exclusively driven by alpha motorneurons It has considerably fewer muscle 
spindles than intercostal muscles and has little postural activity 6 
In patients with COPD, however, strength and endurance of the diaphragm 
may be affected by its unfavourable position on the length-tension curve 
because of hyperinflation and other factors such as hypoxemia, hypercapnia 
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and the use of corticosteroids 7 9 In a former study, we found a significant 
correlation between respiratory muscle strength (maximal inspiratory mouth 
and transdiaphragmatic pressures) and nocturnal saturation 10 However, it is 
not known if this is a causal relationship Because inspiratory muscle training 
can improve respiratory muscle strength 11~13, this may possibly lead to higher 
nocturnal saturations 
Therefore, the aim of this study was to answer the physiologic question whether 
there is a causal relationship between respiratory muscle dysfunction and 
nocturnal saturation It was hypothesized that target-flow inspiratory muscle 
training (TF-IMT) should result in improved nocturnal saturation by increased 
respiratory muscle strength and in particular diaphragm strength, in patients 
with severe COPD 
7.3 METHODS 
Study design and training 
In a single-blind intervention study the effects of TF-IMT on respiratory muscle 
performance and nocturnal saturation data were compared with sham TF-IMT 
in 20 patients with COPD Informed consent was obtained from all patients The 
study was approved by the hospital medical ethics committee 
Inspiratory muscle training was performed at home, daily during two periods of 
15 minutes using an incentive flow meter (Inspirx, Resprecare Medical Ine, The 
Hague, The Netherlands) with an added resistance in the mouthpiece 12 
Instruction on how to use the training device was given by one of the investiga-
tors The patients had to generate an inspiratory flow rate at which the ball in 
the flow meter reached the top of the device (target-flow) The expiration was 
unloaded The adjustable leak in the flow meter was set so that the patients had 
to generate either 60% or 10% of their maximal inspiratory mouth pressure to 
attain the target flow Every week, a physiotherapist of our institute checked if 
the manoeuvres were performed correctly Plmax was measured every week 
If it was changed, the leak was adjusted according to the new Plmax The 
inspiratory and expiratory time were set at 3s and 4s, respectively 
Patients 
Twenty patients with COPD (5F), according to the standards of the American 
Thoracic Society 14, were selected if their mean nocturnal arterial oxygen 
saturation was lower than 92 % All patients were in a stable condition at the 
time of study as defined by a fluctuation in FEVi of less than 10% in the 
preceding six months Patients with other pulmonary diseases, chest wall 
deformations, a previous thoracotomy, diabetes mellitus, neuromuscular dis-
eases, obstructive sleep apnoea/hypopnoea syndrome oran overlap syndrome 
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were excluded. None used medication which stimulated or depressed respi-
ration. The patients were randomized to receive either TF-IMT at 60%, or sham 
training at 10% of their Plmax during 10 weeks. Evaluation was performed in 
weeks 0, 4 and 10. Patient characteristics and lung function data are summa-
rized in Table 1. Pulmonary medication, as shown in Table 2, was not changed 
during the study period. 
Table 1 
Patient characteristics 
Variables 
age (yrs) 
pack years 
BMI (kg/m2) 
TLC (% pred) 
FRC (% pred) 
FEV, (% pred) 
FEV,/IVC (% pred) 
KCO (% pred) 
Pa02 (kPa) 
PaC02 (kPa) 
TF - IMT 
60% Plmax 
62.4 (8.8) 
19.1 (7.8) 
23 7 (3.3) 
105.0(18.5) 
130 0(22.3) 
3B2 (15 1) 
35.6(12 5) 
47 6(19 3) 
8 6(1 1) 
6 1 (1.0) 
TF - IMT 
10% Plmax 
61 8 (7.3) 
27 1 (19 3) 
23.0 (3.2) 
103 6(21 7) 
137 7(40 0) 
32 8(13 0) 
32 7(13 0) 
45.4(22 1) 
8.7 (1 0) 
5 8 (0 9) 
TF-IMT target-tlow inspiiatoiy muscle training, Plmax maximal inspiratory mouth pressure, 
BMI body mass index, TLC total lung capacrty, FRC functional residual capacity, 
FEVi-forced expiratory volume in 1 second, /VC inspiratory vital capacity, KCO diffusion capacity 
Data are expressed as means (SDJ 
Pressure measurements (force and endurance) 
Maximal inspiratory and expiratory mouth pressures (Plmax, PEmax) were 
measured with a device based on that used by Wilson and colleagues 15. A 
small leak (internal diameter 1.1 mm, length 40 mm) in the mouthpiece 
prevented the buccal muscles from producing significant pressures and from 
closing the glottis. The pressure inside the mouthpiece was measured with a 
pressure transducer (Validyne DP103-32, Northridge, California, range ± 40 
kPa). Transdiaphragmatic pressure (Pdi) was measured with a flexible double 
lumen catheter (internal diameter of each lumen 1.1 mm) introduced through 
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the nose 16 The catheter was positioned with the distal opening of the gastric 
lumen 58 cm from the nares and the proximal opening of the oesophageal 
lumen 38 cm from the nares The catheter was perfused with water at a constant 
flow rate of 99 ml/hour The pressure generated by the water flow was 1 2 kPa 
The proximal ends of the double lumen catheter were connected to two 
pressure transducers The zero reference point was arbitrarily set as the 
pressure measured at functional residual capacity (FRC). Pdi was calculated 
Table 2 
Pulmonary medication 
Medication 
Inhaled beta agonists 
Inhaled anticholinergics 
Inhaled corticosteroids 
Oral corticosteroids (5-10 
Oral theophyllines 
mg) 
TF - IMT 
60% Plmax 
(no. patients) 
10 
10 
10 
2 
θ 
TF - IMT 
10% Plmax 
(no. patients) 
10 
6 
10 
1 
10 
by subtracting oesophageal pressure (Poes) from gastric pressure (Pga) 
Plmax, PEmax, Poes and Pga were displayed on a chart recorder (Kipp & 
Zonen, BD 101, Delft, the Netherlands) Pdi was measured with visual feedback 
on the chart recorder and the patients were encouraged to generate the highest 
deflections LaPorta et al 17 showed that in this way the highest Pdi values were 
obtained in patients with COPD Pressure measurements were performed in 
sitting position, with the subjects wearing a noseclip 
Plmax (from RV) and PEmax (from TLC) were repeated until three reproducible 
measurements had been performed with a maximal variability of 10% 17 The 
highest values were used for analysis For the sake of convenience, Plmax was 
expressed as an absolute value Predicted values for Plmax and PEmax were 
calculated according to Wilson and colleagues 1 5 
Respiratory muscle endurance was measured using a device similar to that 
described by Nickerson and colleagues1θ Patients inspired against a weighted 
plunger They had to generate a certain threshold pressure (Pth) to lift the 
plunger and allow air to flow Rh could be varied by adding weight to the 
/K. 
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plunger Rh was measured inside the mouthpiece with a pressure transducer 
There was a linear relationship between Pth and the weight on the plunger The 
patients started with a load of about 10% of their Plmax and 25 or 50g weights 
were added at 1 5-min intervals 19 They continued to breathe until they could 
no longer inspire The total time they were able to breathe through the 
incremental threshold device was defined as the endurance time The pressure 
achieved during the heaviest load tolerated for at least 45s was defined as the 
maximal sustainable inspiratory pressure (SIPmax)19 
Nocturnal recordings 
During the night oxygen saturation and heart rate were measured in a real-time 
format by a pulse-oximeter (Oxyshuttle, Sensor Medics, Anaheim, California) 
The data were stored and digitized Computerized analysis provided mean 
nocturnal saturation (NSaCte), standard deviation and a histogram of the 
distribution of % Sa02-values The baseline ЭаОг awake was defined as the 
mean saturation during the first 15 minutes of the record, when the patient was 
awake and lying flat2 0 Desaturation was defined as a decrease by more than 
4% in oxygenation from the baseline saturation awake, for a period of 5 minutes 
or more This definition was derived from the study of Block and colleagues 2 1 
who described that a desaturation was clinically noteworthy when a fall of 4 % 
or more occurred and from the study of Fletcher and colleagues1 who defined 
a nocturnal desaturation as a fall below 90% lasting at least 5 minutes 
End-tidal PCO2 (PetCCte) was measured with a sampling capnograph (Mijnhart 
Capnolyser, Bilthoven, The Netherlands) by introducing a catheter into the 
naso-pharyngeal cavity through a nostril In this way РеЮОг was monitored 
both during mouth and nasal breathing Because РеГСОг is not representative 
of arterial PCO2, increases in PetCCte were only used qualitatively as indicators 
of hypoventilation in combination with the saturation and thoracic movement 
signals 2 2 
Thoracic movements were measured by means of respiratory inductive 
plethysmography (Vitalog, Bear Island, California USA), which was used to 
indicate if there was respiratory activity at al l 2 3 
An electro-oculogram (EOG) was performed with surface electrodes The EOG 
signal was used for visual scoring of wakefulness, non-REM and REM sleep 
2 3
 When rapid eye movements were present in combination with desatura-
tions, it was even more likely that REM sleep was present24 Oxygen saturation, 
heart rate, thoracic movement, electro-oculogram and РеКЮг signals during 
the night were displayed on a six-channel chart recorder (Kipp & Zonen, 
BD101, Delft, The Netherlands) The next morning the nocturnal recordings 
were analyzed by a technician of the lung function laboratory who was unaware 
of the treatment modality At least one episode of REM sleep should be present 
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before accepting the nocturnal registration as representative The St Mary's 
hospital sleep questionnaire was used for assessing the quality of sleep in the 
preceding night25 
Lung function and blood gas analysis 
Lung function tests were performed with a wet spirometer and by a closed-cir­
cuit helium-dilution method (Pulmonet III, Sensormedics, Bilthoven, The Neth­
erlands) Diffusion capacity (KCO) was measured by the single breath-holding 
carbon monoxide method (Sensormedics 2450) Predicted spirometrie values 
were taken from ERS standards 2 6 
Arterial blood gas samples were taken in semirecumbent position at 09 00 am, 
after the patients had been lying down for at least 15 minutes (Corning Ph 127) 
Statistical analysis 
Data are expressed as means ± SD The Wilcoxon signed rank test was 
performed to test differences within the groups after 10 weeks of TF-IMT at 60 
or 10% of Plmax The Mann-Whitney-U test was used to test the difference 
between the two groups after training The Spearman correlation test was used 
to analyse correlations between changes in respiratory muscle performance 
and changes in nocturnal saturation A p-value < 0 05 was considered signifi­
cant For all analyses the SAS package (SAS Institute Ine, Cary, North Carolina, 
USA) was used 
7.4 RESULTS 
Patients 
Ten patients (3F) underwent TF-IMT at 60% and 10 patients (2F) received sham 
TF-IMT at 10% of their Plmax There were no significant differences in age, body 
mass index, lung function and daytime arterial blood gases between the groups 
(Table 1) During the training period daytime blood gases did not change in the 
60% Plmax group, wheras РаОг decreased by 0 7 kPa in the 10% Plmax group 
РаСОг, FEVi and FRC did not change in either group All patients finished the 
complete study period 
Effects of IMT on maximal respiratory pressures and endurance 
Table 3 shows the effects of 10 weeks' TF-IMT on respiratory muscle perform­
ance In both groups Pdi could not be measured in three patients, because they 
were not able to swallow the double lumen catheter Plmax, Pdi (Figure 1), 
SIPmax and the endurance time increased significantly in the 60% training 
group, while no change was seen in the 10% sham training group For all 
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Table 3 
Respiratory muscle performance 
Week 
Plmax (kPa) 
(% pred) 
Pdi (kPa) 
PEmax (kPa) 
(% pred) 
SIPmax (kPa) 
time (s) 
TF - IMT 
60% Plmax 
0 
6 2 (1 2) 
81 7 (15 7) 
6 6 (1 8) 
10 4(2 8) 
90 5 (22 0) 
2 9 (1 7) 
437 (209) 
10 
9 2(2 0 ) * * * * 
120 4(26 8) 
10 0(3 4)*** 
11 7(4 0)*** 
101 5(28 3) 
4 4(2 3 ) * * # # # 
626 (245)**** 
TF - IMT 
10% Plmax 
0 
5 6 (1 5) 
73 0(19 0) 
5 8 (1 3) 
8 5 (2 7) 
73 3 (22 0) 
2 3 (0 9) 
469 (223) 
10 
5 8 (1 4) 
76 3(18 6) 
6 0 (1 6) 
7 6 (2 8) 
64 3 (21 2) 
2 0 (0 8) 
419(181) 
TF-IMT target flow inspiiatory muscle training, Plmax maximal inspiratory mouth pressure, 
Pdi maximal inspiratory transdiaphragmatic pressure PEmax maximal expiratory mouth pressure, 
SIPmax maximal sustainable inspiratory mouth pressure, time endurance time 
Data are expressed as means (SD) 
Pdi (kPa) 
14 
12 -
10 
r 
10 
Time (weeks) 
Figure 1 Effects ot TF-IMT on maximal inspiratory transdiaphragmatic pressure 
Closed squares represent 60% Plmax group, open rounds represent 10% Plmax group 
* ρ < 0 05 within 60% Plmax group, ** ρ <0 01 between the two groups 
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parameters there was a significant difference between the training group and 
the control group. PEmax improved significantly in the 60% Plmax group (1.3 
[2.3] kPa). There was also a significant difference in PEmax between the two 
groups. 
Effects of increased respiratory muscle strength and endurance on nocturnal 
saturation 
In the 60% Plmax group the mean subjective sleep time, assessed by the St. 
Mary's hospital sleep questionnaire was 4.7 (1.3) hours and 5.3 (1.5) hours in 
week 0 and 10, respectively. In the 10% Plmax group, the patients slept 4.8 (1.2) 
and 4.7 (1.6) hours, respectively. 
The effects of TF-IMT on nocturnal parameters are shown in Table 4. All 
desaturations were of the non-obstructive type and were caused by hypoven­
tilation. After 10 weeks of TF-IMT, the mean nocturnal saturation (NSaCte) 
increased significantly by 1.9 (2.2) % in the 60% Plmax group, while it decreased 
by 0 9 (1.5) in the control group (p=0.16). A significant difference of 2.8 % 
Table 4 "| 
Nocturnal recording data 
Week 
Time In bed (min) 
HEM sleep (min) 
Non-REM sleep (min) 
NSa02 (%) 
Lowest NSa02 (%) 
% time des (%) 
Sa0 2 < 90% (% time) 
TF - IMT 
60% Plmax 
0 
474 (29) 
47(19) 
255 (42) 
8Θ 8 (3 0) 
80 3 (9 6) 
18 6(18 0) 
55 5 (42 3) 
10 
466 (38) 
46 (20) 
263 (50) 
90 7 (1 7 ) * # # 
83.6 (7 8)* # 
5 4(5 4)** 
28.4(35 0)** 
TF - IMT 
10% Plmax 
0 
466 (33) 
48(19) 
242 (40) 
89.3 (1 9) 
81 7 (4.2) 
17 4(27 8) 
59.1 (40 3) 
10 
478 (23) 
47(19) 
248 (47) 
88 4 (2 7) 
79 3 (6 6) 
16 2(23.3) 
62 5 (37 6) 
TF-IMT target-flow inspiratory muscle training. Plmax maximal inspiiatory mouth pressure. REM rapid eye move­
ment, NSaOi mean nocturnal arterial oxygen saiurai/on, % time des percentage of recording time patients were de-
saturated, lowest ЛКаОг lowest nocturnal arterial oxygen saturation, ВаОг < 90% (% time) percentage of recording 
time patients had a saíu/aí/οπ below 90%, * ρ < 0 05 within the group, # ρ < 0 05, # # p < 0 01 between the (wo 
groups 
Data are expressed as means (SD) 
& 
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95 -
93 
91 
Θ9 
87 
## 
9 — - — • = -
85 -
ut L. 
10 
Time (weeks) 
Figure 2 Effects of TF-IMT on mean nocturnal saturation (NSaOn) 
Closed squares represent 60% Plmax group, open founds represent 10% Plmax group 
* ρ < 0 05 within 60% Plmax group, **ρ <001 between the two groups 
Lowest NSa02 (%) 
95 -
90 
85 
80 
75 
70 
0 
10 
Time (weeks) 
figure 3 Effects of TF-IMT on the lowest nocturnal saturation 
Closed squares represent 60% Plmax group, open rounds represent 10% Plmax group 
* ρ < 0 05 within 60% Plmax group, * ρ < 0 05 between the two groups 
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Desaturation time (%) 
50 
40 -
30 
20 
10 
0 L 
fc,-
•I. 
10 
Time (weeks) 
Figure 4 Effecte ol TF IMTon the percentage ol recording time patient s were desaturated 
Closed squares represent 60% Plmax group open rounds represent 10% Plmax group 
* ρ < 0 05 within 60% Plmax group * p<0 05 between the two groups 
between the two groups developed (Fig 2) A significant increase of 3 3 (4 8) % 
in the lowest saturation was observed in the 60% Plmax group In the control 
group no significant difference developed (p=0 19) The difference in the lowest 
NSaO? between the two groups was significant (Fig 3) The percentage of 
recording time during which patients were desaturated decreased by 13 2 
(13 5) % in the 60% Plmax group (p < 0 05) In the 10% Plmax group no change 
occurred (p=0 68) The difference between the groups was significant (Fig 4) 
Also the percentage of recording time patients were hypoxemic (SaÜ2< 90%) 
14
 before and after TF-IMT were compared A large improvement was observed 
in the 60% Plmax training group the percentage of recording time spent at a 
saturation below 90% decreased from 55 5 (42 3) to 28 4 (35 0) %, while in the 
sham training group the saturation remained below 90% during a large part of 
the night (59 1 [40 3] and 62 5 [37 6] %, respectively) (Fig 5) In addition, at the 
start of the study 7 of the 10 patients in the 60% Plmax training group 
experienced periods with a saturation below 85% (range 0 4 -90 % recording 
time, mean 18 7 [33 2] %) The time spent below 85% Sa02 decreased in all 
these patients after TF-IMT, but the largest improvement was observed in the 
two patients with the most severe desaturations In these patients the recording 
time spent below 85% БаОг decreased from 90 0 to 20 8 % and from 71 2 to 
3 0%, respectively 
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Correlations between respiratory muscle function and nocturnal saturation 
Significant correlations were found between the change in mean nocturnal 
Sa02 and the change in Pdi (r=0.67, ρ < 0.01), SIPmax (r=0.54, ρ < 0.05) 
and the endurance time (0.53, ρ < 0.05). The correlation coefficient between 
the change in mean NSa02 and the change in Plmax was 0.43 (p=0.06). 
TlmeNSaO2<90%(%) 
100 -
weekO week 10 
60% Plmax 
week 0 week 10 
10% Plmax 
Figure 5 Effects ol TF-IMT on the peitentage of recording time patient's SaO? was tower trian 90%. 
Each set of dots, connected by a line, represents one patient 
* ρ < 0 05 within 60% Plmax group, * ρ < 0 05 between the two groups 
7.5 DISCUSSION 
The present study shows that TF-IMT at 60% of Plmax improves static maximal 
inspiratory mouth pressure, static maximal inspiratory transdiaphragmatic 
pressure and respiratory muscle endurance in patients with severe COPD. This 
improvement in respiratory muscle function appears to result in an increase of 
the mean and lowest nocturnal saturation, a decrease of the percentage of 
time desaturations occurred and a reduction of time spent below а ЭаОг of 
90%, compared with the control group who received sham training at 10% 
Plmax. These changes suggest that respiratory muscle function plays a role in 
nocturnal saturation in patients with COPD. The results of inspiratory muscle 
training in patients with COPD are conflicting. Some studies showed an 
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increase in Plmax and endurance 11"13, but this was not confirmed by other 
investigators27 2 9 In these latter studies inspiratory flow, breathing pattern and 
inspiratory pressure were not defined, probably resulting in an inadequate 
training stimulus 2 7 2 9 Therefore, in the present study the breathing pattern 
(inspiration time 3s, expiration time 4s) as well as the target flow at a fixed 
inspiratory resistance, resulting in a fixed inspiratory pressure (60% or 10% 
Plmax), were explicitly defined As far as we know, the improvement of Pdi by 
inspiratory muscle training (Fig 1) has not been described before 
PEmax increased significantly by 1 3 kPa in the 60% training group and a 
significant difference was noticed between the two groups This might be 
explained by the fact that, before performing an inspiratory manoeuvre during 
TF-IMT, patients were encouraged to expire as far as possible to make it easier 
to generate the required pressure This was done because the highest inspira­
tory pressures can be generated at RV with a gradual decrease at increasing 
lung volumes 3 0 It may therefore be speculated that expiratory muscles were 
also trained to some extent during TF-IMT In the present study, Plmax and Pdi 
were measured from RV instead of FRC, because the predicted values for Plmax 
according to Wilson and colleagues 15 were also measured at RV This overes­
timates Plmax because of the elastic recoil pressure of the lung and chest wall 
The increase in mean nocturnal SaCte (Fig 2) could not be explained by an 
increase in daytime РаОг or FEVi, because these parameters remained un­
changed in the 60% training group Therefore the improved nocturnal saturation 
may be a direct consequence of the improved respiratory muscle performance 
This is supported by the significant correlation coefficients found between the 
change in respiratory muscle function and the change in mean nocturnal БаОг 
The improvement of Pdi is then likely to cause a decrease in desaturation time 
(Fig 3) and an increase in the lowest nocturnal Sa02 (Fig 4) resulting in an 
increase of the mean nocturnal saturation (Fig 2) 
Electroencephalography was not performed in this study, so it was not possible 
to obtain classical sleep staging However, eye movements taken from EOG 
are sufficiently characteristic to allow visual scoring of wakefulness, non-REM 
and REM sleep 2 3 During the study, the time spent in non-REM and REM sleep 
stage by the patients did not change 
An acclimatization night was not used because most patients had undergone 
a nocturnal registration before and were accustomed to the procedure Strad-
hng and colleagues 2 showed that the mean and lowest nocturnal saturation 
during consecutive nights were very similar in patients with COPD Similar 
findings were observed by Gothe and colleagues 31, who studied the oxygen 
saturation and breathing pattern during two non-consecutive nights in patients 
with COPD In our control group the mean and lowest nocturnal БаОг as well 
2 ^ 
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as the percentage of time patients were desaturated did not change either 
during the study In addition, the amount of REM sleep remained constant 
The present study was performed in a single-blind fashion, but the nocturnal 
recordings were analyzed by a technician of the lung function laboratory who 
was unaware of the treatment modality In addition, the respiratory muscle 
measurements were performed without knowledge about the nocturnal satu­
ration data 
The course of the present study was too short and it was not designed to 
evaluate the influence of increased NSa02 or decreased desaturation time on 
polycythemia, cor pulmonale, cardiac arrhythmias and survival However, in 
studies with a comparable percentage of desaturation time, adverse clinical 
effects were found In the study of Levi-Valensi and colleagues 3 2 a correlation 
(r=0 33) between the total duration of saturation dips and pulmonary hyper­
tension in 40 patients with COPD (daytime РаОг 8 0-93 kPa) was found A 
desaturation was defined as a fall of 4% from the baseline awake value The 
mean nocturnal desaturation time was 56 mm These authors also showed that 
pulmonary hypertension was only present in 6 out of 18 patients in the 
desaturating group In these 18 patients the desaturating time was 105 mm In 
the 22 non-desaturating patients no pulmonary hypertension was present 
These findings correspond with the data published by Fletcher and colleagues 
3 3
 These authors found that the pulmonary arterial pressure was significantly 
higher in desaturating (n=36) than in non-desaturating (n = 13) patients with 
COPD and a daytime РаОг >60 mm Hg The mean nocturnal desaturating 
time in the desaturating patients was 56 mm So, although we did not measure 
pulmonary arterial pressure in our patients, pulmonary hypertension was likely 
to be present in at least some of our patients, because the desaturation time 
in our study (88 mm) is comparable to the desaturation time in the above 
mentioned studies in which pulmonary hypertension was found To our knowl­
edge, no placebo-controlled studies have been published on the effects of a 
decrease in desaturation time, induced by oxygen, respiration stimulating 
medication or training, on the pulmonary artery pressure As a consequence, 
the question whether a decrease in desaturation time as found in the present 
study to some extent reverses its clinical sequelae cannot be answered 
directly The data on effects of nocturnal hypoxemia on survival are conflicting 
and difficult to compare Connaughton and colleagues w found in 97 patients 
with COPD (FEVi 24 9 [9 0] % pred, РаОг 55 [10] mmHg) that patients who 
were more hypoxemic at night than predicted from the regression relationship 
during the day, had a survival similar to that of the patients who were less 
hypoxemic than predicted In the regression relationship, daytime ЭаОг was 
the only predictive variable The authors concluded that the seventy of noctur­
nal hypoxemia did not influence the prognosis However, in their study many 
A 
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patients were already hypoxemic during the day, so that effects of nocturnal 
hypoxemia alone on survival could not be estimated In contrast, Fletcher and 
coworkers 34 showed in 169 patients with COPD (mean FEVi 35% predicted, 
who were all normoxemic [daytime РаОг >60 mm Hg]) that desaturating 
patients (mean desaturation time [below 90% БаОг] 134 mm) had a worse 
survival than non-desaturating patients (mean survival 2 9 (1 7) and 3 7 (1 7) 
years, respectively) Furthermore, 5-year survival was also significantly better in 
the non-desaturating group The effects of oxygen on survival in the desaturat­
ing group showed a trend toward shorter survival in the non-oxygen treated 
group However, these investigators did not describe the amount of oxygen 
administered nor the effects of oxygen on nocturnal saturation 
The increase of 1 9 (2 2)% in the mean nocturnal saturation and the substantial 
decrease in desaturation time (13 2 [13 5]%) in the 60% Plmax training group 
in our study might be of clinical importance, since the complications of nocturnal 
hypoxemia as mentioned earlier were described especially in desaturating 
patients In addition, the time spent below 90% SaCte during the night was 
significantly reduced (Fig 5) This reduction might possibly reduce the risk of 
developing pulmonary hypertension during the night 
In conclusion, this study shows that TF-IMT at 60% of Plmax improves the 
nocturnal saturation in patients with COPD This improvement is caused by an 
increased Plmax and Pdi in particular as well as an increased respiratory muscle 
endurance 
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Summary and conclusions 
8.1 SUMMARY AND CONCLUSIONS 
Patients with moderate to severe COPD run a high risk of desaturating during 
the night The most important reason is hypoventilation, which mainly occurs 
during REM sleep One of the causes of hypoventilation is a decreased activity 
of the intercostal and accessory muscles This appears to be caused by 
supraspinal inhibition of gamma motorneurons Because the diaphragm is 
driven almost exclusively by α-motomeurons, it escapes from reduction of 
activity during REM sleep 
However, in patients with COPD, strength and endurance of the diaphragm 
may be decreased because of the unfavourable position on the length-tension 
curve due to hyperinflation Other factors impairing the function of the dia­
phragm in these patients are hypoxemia, hypercapnia and the use of cortico­
steroids We hypothesized that patients with decreased maximal inspiratory 
muscle strength could have a lower nocturnal saturation than patients with 
normal respiratory muscle strength If this relationship was found, this could 
have clinical consequences, because target-flow inspiratory muscle training 
(TF-IMT) improves inspiratory muscle strength and endurance and conse­
quently possibly also the nocturnal saturation in these patients 
The aims of this thesis were 
1 .To investigate the differences between maximal static and maximal dynamic 
inspiratory mouth pressure measurements (Chapter 3) 
2. To study the influences of body position, hyperinflation and arterial blood 
gas tensions on maximal inspiratory mouth and transdiaphragmatic pressure 
(Plmax, Pdi) in patients with COPD (Chapter 4) 
3. To study the relationship between maximal inspiratory muscle strength and 
nocturnal saturation parameters (Chapter 5) 
4 To study if a decreased respiratory muscle strength contributes to hypox­
emia during an acute exacerbation of COPD (Chapter 6) 
5. To investigate if TF-IMT improves the nocturnal saturation (Chapter 7), 
because a positive correlation was found between maximal inspiratory muscle 
strength and nocturnal saturation (Chapter 5) 
Plmax and Psniff are often used to measure inspiratory muscle strength 
Chapter 3 describes the question of interchangeabihty of these two measure­
ments and the influence of body posture on Plmax and Psniff as well as the 
effects of nasal patency and repeated manoeuvres on Psniff in 42 healthy 
subjects This study showed that the measurement methods were not inter­
changeable because of the low agreement between Plmax and Psniff Plmax 
and Psniff were higher in a sitting position than in a supine position and Psniff 
performed with one nostril open was higher than with two open nostrils After 
2гз\ 
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20-28 sniff manoeuvres Psniff decreased, suggesting some form of inspiratory 
muscle fatigue 
The consequence of this study was that in the next studies respiratory muscle 
strength was measured in a static fashion, because the advantages of Psniff 
mentioned in the literature, such as higher values and no fatigue, were not 
confirmed Besides, it was important that longitudinal measurements were not 
influenced by differences in nasal patency The difference between respiratory 
pressures in sitting and supine position was investigated, because we aimed 
to study the relationship between respiratory muscle strength and nocturnal 
saturation, when patients are in a supine position 
Chapter 4 describes the influences of body position, hyperinflation and blood 
gas tensions on Plmax and Pdi in 30 male patients with COPD (FEVi 40 4 % 
pred) Plmax in supine position was lower than Plmax in sitting position, where 
as Pdi, in contrast to healthy subjects, was higher in the supine postion than in 
the sitting position An explanation might be, that in the supine position the 
abdominal contents displace the flattened diaphragm upwards leading to a 
more favourable position on the length-tension curve In the supine position 
there is a decreased activity of the accessory and parasternal-mtercostal 
muscles, combined with a decreased compliance of the rib cage However, the 
increased force generated by the diaphragm apparently cannot compensate 
for this decreased activity, because Plmax in the supine position was lower 
Apart from the influence of body position on inspiratory muscle strength, 
significant correlations were found between inspiratory muscle strength on the 
one hand and static and dynamic lung function parameters and arterial blood 
gas tensions on the other Multiple regression analysis showed, that the degree 
of hyperinflation and/or ЭаОг were the best predictors of Plmax and Pdi The 
predictive values were 30 and 43%, respectively 
In chapter 5 the relationship between nocturnal saturation parameters and 
inspiratory muscle strength was investigated Thirty-four patients with COPD 
and a wide range of airway obstruction (FEVi mean (SD) 41 7 (19 9) % pred) 
were studied The significance of daytime Sa02 in predicting nocturnal satura­
tion was described previously It is unknown if inspiratory muscle strength 
contributes to the prediction of the nocturnal saturation Of the 34 patients, 16 
developed episodes with desaturations, caused by hypoventilation, during the 
night A desaturation was defined as a decrease of more than 4% below 
baseline awake saturation lasting at least 5 minutes Significant correlations 
were found between the mean nocturnal saturation and Plmax (r=0 65) and 
between the mean nocturnal saturation and Pdi (r=0 53) Also significant 
correlations were found between the nocturnal saturation and other daytime 
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parameters such as FEVi (r=0 61), KCO (r=0 38), SaCte (r=0 75) and РаСОг 
(r=-0 44) However, multiple regression analysis showed that, although there 
were significant correlations between inspiratory muscle strength and noctur­
nal saturation, daytime SaCfe (70%) and FEV1 (5%) were the most important 
predictors 
In chapter 6 the effects of an exacerbation on respiratory muscle strength and 
nocturnal saturation were studied in eleven patients with COPD Maximal 
inspiratory muscle strength is influenced by factors such as hyperinflation, 
hypoxemia and hypercapnia During an exacerbation all these factors may 
worsen, deteriorating the already lower inspiratory muscle strength m patients 
with COPD even more In 9 patients we measured lung function, blood gas 
values, respiratory muscle strength and nocturnal saturation on the first or 
second day after admission to hospital, and after 2 and 12 weeks In 2 patients 
the measurements after 12 weeks could not be performed, because they had 
become oxygen-dependent This study showed that Plmax was significantly 
lower one day after admission than 2 weeks later This was caused by 
hyperinflation, because after correction for hyperinflation, the standardised 
Plmax values were the same on day 2, and after 2 and 12 weeks Furthermore, 
no correlations were found between the change in Plmax and the change in 
nocturnal or daytime saturation Therefore, we concluded that Plmax was 
significantly lower during an exacerbation, but this did not contribute to a lower 
saturation during the day or night The lower saturation during an exacerbation 
seemed to be caused by venous admixture 
Two hypotheses were formulated after the conclusions of chapters 4 and 5 
The first hypothesis was that respiratory muscle strength influences the day­
time saturation and the daytime saturation influences the nocturnal saturation 
The other hypothesis was that respiratory muscle strength directly influences 
the nocturnal saturation In that case, the contribution of the inspiratory muscle 
strength to the prediction of the nocturnal saturation is probably relatively small, 
because daytime SaCte and the FEVi already predict 75% of the nocturnal 
saturation Therefore, an intervention study was designed in which the effects 
of TF-IMT on saturation parameters were studied 
In chapter 7 the effects of TF-IMT during 10 weeks on the nocturnal saturation 
were studied A single-blind placebo-controlled intervention study was de­
signed Twenty patients with a nocturnal saturation lower than 92% were 
included The respiratory muscle endurance was measured with an incre­
mental threshold loading device The pressure achieved at the heaviest load 
tolerated for at least 45s was defined as the maximally sustainable inspiratory 
pressure (SIPmax) TF-IMT was performed with an incentive flow meter with an 
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added resistance and an adjustable leak stream. Ten patients were trained at 
60% of their Plmax. The other 10 received sham-training at 10% Plmax. The 
patients trained two times a day during 15 minutes. The results are summarized 
in Table 1. 
Table 1 
The effects of TF - IMT on respiratory muscle strength, respiratory muscle 
endurance and nocturnal saturation parameters 
Week 
Plmax (kPa) 
Pdl (kPa) 
PEmax (kPa) 
SIPmax (kPa) 
time (s) 
NSa02 (%) 
Lowest NSa02 (%) 
% time des (%) 
1 
0 
6 2 (1 2) 
6 6(1 8) 
10 4(2 8) 
2 9 (1 7) 
415(219) 
88 8 (3 0) 
80 3 (9 6) 
186(171) 
training 
30% Plmax 
10 
9 2 (2 0 ) * * * * 
10 0(3 4 ) * # # 
11 7(4 0 ) * # # 
4 4(2 3 ) * * * * * 
626(245)**** 
90 7(1 7)*** 
83 6(7 8)** 
5 4(5 1)** 
sham-tralnlng 
10% Plmax 
0 
5 6 (1 5) 
5 8 (1 3) 
8 5 (2 7) 
2 3 (0 9) 
469 (223) 
89 3 (1 9) 
81 7 (4 2) 
17 4(27 8) 
10 
5 8 (1 4) 
6 0 (1 6) 
7 6 (2 8) 
2 0 (0 8) 
419(181) 
88 4 (2 7) 
79 3 (6 6) 
16 2(23 3) 
Plmax maximal inspiratory mouth pressure Pdi maximal inspiratory transdiaphragmatic pressure, PEmax maximal ex­
piratory mouth pressure. SIPmax maximal sustainable inspiratory mouth pressure, time total time of the incremental 
threshold experiment, NSaOi mean nocturnal saturation, lowest NSaOi lowest nocturnal saturation, % time des per­
centage ol time patients are desaturated, 
'p<005, "p< 0 01 within the 60% Plmax group, *p<0 05, "* ρ <001, *** ρ < 0 001 between the two 
groups 
Plmax, Pdi, SIPmax as well as nocturnal saturation parameters improved in the 
60% Plmax training group, while no change was seen in the 10% Plmax training 
group. Lung function parameters and arterial blood gas tensions during the day 
remained stable during the whole training period, except for a small decrease 
of РаОг in the 10% Plmax training group. Significant correlations were found 
between the change in respiratory muscle strength and the change in nocturnal 
saturation. The conclusion of this study was that inspiratory muscle training 
improved nocturnal saturation. 
Summery and conclusions 
Ζ 
The clinical consequence of this study is that patients with mild hypoxemia 
during the night can be treated with TF-IMT So far, it has not been advised to 
treat nocturnal hypoxemia with supplemental oxygen because the effects on 
pulmonary hypertension, cor pulmonale and survival are not known yet, while 
it is a relatively expensive treatment modality 
In conclusion, there is a causal relationship between inspiratory muscle 
strength and nocturnal saturation in patients with COPD TF-IMT improves 
respiratory muscle strength and endurance, while at the same time nocturnal 
saturation improves 
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Samenvatting en conclusies 
9.1 SAMENVATTING EN CONCLUSIES 
Patienten met een matig tot ernstig chronisch obstructief longlijden (COPD) 
hebben een grote kans op een daling van het zuurstof gehalte in het arteriele 
bloed De belangrijkste oorzaak is hypoventilatie Deze verminderde ventilatie 
is het meest uitgesproken gedurende de REM slaap, omdat in deze fase de 
activiteit van de hulpademhalingsspieren en intercostaalspieren is afgenomen 
Dit wordt veroorzaakt door inhibitie van gamma-motorneuronen Het dia-
fragma wordt voornamelijk geinnerveerd door alpha-motorneuronen, daar-
door behoudt het zijn normale neuronale activiteit 
In de hierboven beschreven categorie patiënten kunnen kracht en uithou-
dingsvermogen van het diafragma verminderd zijn als gevolg van een ongun-
stige plaats op het kracht-lengte diagram, hetgeen veroorzaakt wordt door 
hyperinflatie Andere factoren die de functie van het diafragma van patiënten 
met COPD ongunstig beïnvloeden zijn hypoxemie, hypercapnie en het gebruik 
van corticosteroiden 
Onze hypothese was dat COPD-patienten met een verminderde maximale 
inspiratore spierkracht gemeten aan de mond of transdiafragmaal (Plmax, 
Pdi), een lagere nachtelijke saturatie hebben dan de patiënten met een 
normale inspiratole spierkracht Indien deze relatie gevonden zou worden zou 
dit praktische consequenties kunnen hebben, aangezien "target-flow" inspira-
tole spiertraining (TF-IMT) zowel de maximale inspiratole spierkracht als het 
duurvermogen van de ademhalingsspieren kan verbeteren In dat geval zou 
TF-IMT een stijging van de nachtelijke saturatie tot gevolg kunnen hebben Dit 
leidde tot de volgende vraagstellingen in het proefschrift 
1 : Wat zijn de verschillen tussen statisch en dynamisch gemeten maximale 
monddrukken bij gezonde proefpersonen (hoofdstuk 3)7 
2: Wat zijn de gevolgen van houdingsverandering (tijdens de slaap liggen 
mensen), hypennflatie en arteriele bloedgaswaarden op statisch gemeten 
maximale inspiratore monddrukken (Plmax) en maximale inspiratore transdia-
fragmale drukken (Pdi) bij patiënten met COPD (hoofdstuk 4)? 
3: Is er een relatie tussen de maximale inspiratore spierkracht en de nachtelijke 
saturatie bij patiënten met COPD (hoofdstuk 5)? 
4: Wat zijn de gevolgen van een exacerbatie op de maximale inspiratore 
spierkracht en draagt dit bij tot een verdere verslechtering van de saturatie 's 
nachts en overdag in patiënten met COPD (hoofdstuk 6)? 
5: BIJ vraag 3 werden positieve correlaties gevonden tussen de maximale 
inspiratole spierkracht en de nachtelijke saturatie Vervolgens werd de 
causaliteit van deze relaties onderzocht door middel van een interventie 
onderzoek waarbij de vraagstelling was of TF-IMT de nachtelijke saturatie kan 
verbeteren (hoofdstuk 7) 
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Statische maximale inspiratole monddrukken (Plmax) en dynamische inspira-
toire monddrukken tijdens een maximale sniff manoeuvre (Psniff) worden vaak 
gebruikt om inspiratore spierkracht te meten Hoofdstuk 3 beschrijft de uitwis-
selbaarheid van deze twee verschillende manieren om monddrukken te meten, 
de invloed van de houding op deze drukken, de invloed van de neusdoorganke-
lijkheid op Psniff en het gevolg van verschillende sniff pogingen op Psniff in 42 
gezonde proefpersonen De resultaten van dit onderzoek waren dat Plmax 
significant hoger was dan Psniff Verder bleken beide meetmethoden niet 
uitwisselbaar te zijn omdat de waarden veel verschilden Psniff- en Plmax-waar-
den waren in de zittende positie hoger dan in de liggende positie Psniff 
gemeten met 1 neusgat open gaf hogere waarden dan Psniff gemeten met 2 
neusgaten open Tenslotte bleek dat er na 20-28 sniff pogingen een vorm van 
'vermoeidheid' optrad die zich uitte in een daling van Psniff 
De consequentie van dit onderzoek was dat WIJ in het vervolgonderzoek 
ademhalingsspierkracht op een statische manier hebben gemeten daar de 
door de literatuur gesuggereerde voordelen van Psniff, namelijk hogere waar-
den en geen vermoeibaarheidsfenomeen, niet door ons konden worden beves-
tigd Daarnaast was het voor het verdere onderzoek van belang, dat 
longitudinale metingen niet beïnvloed zouden worden door verschillen in neus-
doorgankehjkheid Het verschil tussen liggende en zittende drukken was be-
langrijk omdat we het verband tussen nachtelijke saturatie en spierkracht wilden 
bestuderen, waarbij we te maken hadden met een liggende patient 
Hoofdstuk 4 beschrijft een aantal factoren zoals lichaamshouding, hyperinflatie 
en bloedgaswaarden, die van invloed kunnen zijn op Plmax en Pdi in 30 
mannelijke patiënten met COPD (FEVi 40 4% pred) Allereerst werd het effect 
van de houding op Plmax en Pdi bestudeerd Plmax in liggende houding was 
lager dan Plmax in zittende houding terwijl dit voor Pdi, in tegenstelling tot wat 
beschreven is bij gezonde personen, precies omgekeerd bleek te zijn De reden 
van deze tegenstelling zou kunnen zijn dat in liggende houding het afgevlakte 
diafragma van COPD patiënten door de buikmhoud naar boven wordt geduwd 
Hierdoor wordt een gunstiger positie op het kracht-lengte diagram verkregen, 
resulterend in hogere transdiafragmale drukken In liggende houding is er 
tevens een verminderde werking van de hulpademhalingsspieren en paraster-
na l intercostaal spieren, gecombineerd met een verminderde compliance van 
de borstkas De verbeterde functie van het diafragma bleek dit niet te kunnen 
opvangen daar er lagere monddrukken werden gemeten in liggende houding 
Vervolgens werden er significante correlaties gevonden tussen inspiratole 
spierkracht (Plmax, Pdi) aan de ene kant en statische en dynamische longvolu-
mina, de Quetelet index en artenele bloedgas waarden aan de andere kant 
Multiple regressie analyse liet zien dat Plmax en Pdi het best voorspeld konden 
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worden uit de mate van hyperinflatie en/of arteriele zuurstofsaturatie (БаОг), 
waarbij de voorspellende waarden 30 en 43% waren 
In hoofdstuk 5 onderzochten we de relatie tussen de nachtelijke saturatie en 
inspiratore spierkracht Dit onderzoek werd verricht in 34 COPD-patienten met 
ver uiteenlopende waarden van FEVi, SaCte en partiele koolzuurspanning 
(РаСОг) Uit de literatuur was al bekend dat de overdag gemeten SaCte een 
belangrijk voorspellende factor is voor de nachtelijke saturatie Onbekend was 
of er een relatie bestaat tussen inspiratore spierkracht en nachtelijke saturatie 
en of inspiratole spierkracht bijdraagt aan de voorspelling van deze nachtelijke 
saturatie Zestien van de 34 patiënten hadden nachtelijke episoden met 
desaturaties als gevolg van hypoventilatie Hierbij was een desaturatie gede-
finieerd als een daling van de saturatie van meer dan 4% gedurende tenminste 
5 minuten ten opzichte van de saturatie tijdens de eerste 15 minuten van de 
registratie in liggende houding Significante correlaties werden gevonden 
tussen gemiddelde nachtelijke saturatie en Plmax (r=0 65), en tussen de 
gemiddelde nachtelijke saturatie en Pdi (r=0 53) Daarnaast werden signifi-
cante correlaties gevonden tussen de gemiddelde nachtelijke saturatie en 
andere parameters overdag, zoals FEVi (r=0 61), diffusie capaciteit gecor-
rigeerd voor effectief alveolair volume (KCO) (r=0 38), overdag gemeten 
waarden van SaCte (r=0 75) en PaCCte (r= - 0 44) BIJ multiple regressie 
analyse bleken, ondanks de correlaties tussen inspiratole spierkracht en 
nachtelijke saturatie, de SaCte overdag (70%) en FEVi (5%) de belangrijkste 
voorspellers van de nachtelijke saturatie te zijn 
In hoofdstuk 6 werden de gevolgen van een exacerbatie op ademhalings-
spierkracht en nachtelijke saturatie bestudeerd in 11 patiënten met COPD De 
maximale inspiratore spierkracht wordt o a beïnvloed door hyperinflatie, hy-
poxie en hypercapnie Gedurende een exacerbatie kunnen deze factoren 
verslechteren, waardoor de over het algemeen toch al lagere spierkracht bij 
COPD-patienten achteruit kan gaan BIJ 9 patiënten met COPD werden op de 
dag van opname cq de dag daarna, na 2 weken en 12 weken, longfunctie 
parameters, bloedgaswaarden, ademhahngsspierkracht en nachtelijke satu-
ratie onderzocht BIJ 2 patiënten konden we alleen op de eerste 2 tijdstippen 
meten Deze patiënten verslechterden en werden afhankelijk van zuurstof, 
waardoor een derde meting niet verricht kon worden Tijdens een acute 
exacerbatie (de dag na opname) hadden patiënten significant lagere Plmax 
waarden Dit werd veroorzaakt door een toegenomen hyperinflatie, na correc-
tie voor hypennflatie bleken de gestandaardiseerde maximale inspiratole 
monddrukken hetzelfde te zijn op dag 2,14 en 12 weken na opname Er werden 
geen correlaties gevonden tussen de verandering in spierkracht en de veran-
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dering in oxigenatie overdag en 's nachts tijdens het herstel van een exacerba-
re De conclusie is dan ook dat afgenomen inspiratore spierkracht tijdens een 
exacerbatie niet bijdraagt aan een lagere saturatie 's nachts of overdag Deze 
lage saturatie wordt met name veroorzaakt door slechte ventilatie-perfusie 
verhoudingen 
Op basis van de gegevens uit hoofdstuk 4 en 5 werden twee hypothesen 
geformuleerd De eerste hypothese veronderstelt dat ademhalingsspierkracht 
de saturatie overdag beïnvloedt en de saturatie overdag weer de nachtelijke 
saturatie De tweede hypothese is dat de ademhalingsspierkracht rechtstreeks 
de nachtelijke saturatie beïnvloedt In het laatste geval zou de bijdrage van de 
spierkracht bescheiden moeten zijn, gezien de hoge voorspellende waarde van 
de SaÜ2 overdag en de FEVi 
Het doel van hoofdstuk 7 was derhalve tweeledig Ten eerste werd het effect 
van 10 weken "target-flow" inspiratoire spiertraining (TF-IMT) op de inspiratoire 
spierkracht (met name van het diafragma) en het duurvermogen van de 
ademhalmgsspieren nagegaan Vervolgens werd het effect van deze training 
op de nachtelijke SaCte bestudeerd Dit gebeurde in een enkel-blinde, placebo-
gecontroleerde studie bij 20 stabiele COPD-patienten Patienten kwamen in 
aanmerking voor de studie als de nachtelijke SaÜ2 lager was dan 92% Het 
duurvermogen werd bepaald met de "incremental threshold loading" methode 
Hierbij ademen patiënten door een kleppensysteem, waarbij de inspiratieklep 
belast kan worden door middel van gewichtes Een zekere "threshold pres-
sure" moet bij iedere inspiratie overwonnen worden voordat de inspiratieklep 
open gaat Er bestaat een lineair verband tussen de "threshold pressure" en 
het gewicht op de inspiratieklep Deze "threshold pressure" kan groter gemaakt 
worden door elke 90 seconden de inspiratieklep in toenemende mate te 
belasten met gewichten van 25-50 g De druk welke bereikt wordt tijdens het 
hoogste gewicht dat patiënten tenminste 45 s kunnen verdragen is de "maxi-
male volgehouden inspiratoire druk" (SIPmax) 
TF-IMT werd verricht met een "incentive flowmeter" met een toegevoegde 
weerstand en een instelbare lekstroom Tien patiënten werden zodanig getraind 
dat bij elke inspiratie 60% van de maximale monddruk gegenereerd moest 
worden De andere 10 patiënten ondergingen een placebo-training, waarbij 
10% van de maximale monddruk nodig was bij elke inspiratie De inademings-
duur werd vastgesteld op 3 seconden, de uitademmgsduur op 4 seconden 
Patienten moesten 2 maal per dag 15 minuten oefenen 
De resultaten van dit onderzoek zijn samengevat in tabel 1 
Zowel inspiratoire spierkracht, duurvermogen, als nachtelijke saturatie parame-
ters verbeterden in de 60% Plmax trainingsgroep, terwijl geen verandering werd 
gezien in de 10% Plmax trainingsgroep Longfunctie parameters en arteriele 
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Table 1 
Effecten van ¡nspiratoire spiertraining op de ademhalingsspierkracht, 
het ademhalingsspierduurvermogen en de nachtelijke saturatie 
Week 
Plmax (kPa) 
Pdi (kPa) 
PEmax (kPa) 
SIPmax (kPa) 
tijd (s) 
NSa02 (%) 
laagste NSa02 (%) 
% tijd des (%) 
0 
6.2(1.2) 
6 6 (1 8) 
10 4(2 8) 
2 9 (1 7) 
415(219) 
88.8 (3 0) 
80 3 (9.6) 
18.6(171) 
training 
B0% Plmax 
10 
9.2(2 0 ) * * # # 
10 0(3 4 ) * # # 
11.7(40)*** 
4.4 (2.3)***** 
626 (245)**** 
90.7(1.7) * * * 
83.6 (7.8)** 
5 4(5 1)** 
training 
10% Plmax 
0 
5.6 (1.5) 
5 8 (1 3) 
8 5 (2 7) 
2.3 (0.9) 
469 (223) 
89 3(1.9) 
81 7 (4 2) 
17 4(27 8) 
10 
5.8 (1.4) 
6 0 (1 6) 
7.6 (2.8) 
2 0 (0.8) 
419(181) 
88.4 (2.7) 
79.3 (6 6) 
16.2(23 3) 
Plmax maximale inspirato/re monddruk. Pdi maximale inspirato/re transdiatragmale druk, PEmax maximale expira-
taire monddruk, SIPmax maximaal volgehouden monddruk, time totale duur 'incremental threshold' experiment, 
NSaÛ2 gemiddelde nachteli/ke saturatie, laagste NSa02 laagste nachtelijke saturatie, % ti/d des: percentage ti/d 
dat patiënten gedesatureeid waren 
*p <0 05, ** ρ < 0 0 J binnen de 60% Plmax groep, *p < 005, **p <0O1,***p < 0001 tussen de twee 
groepen 
bloedgaswaarden bleven stabiel gedurende de trainingsperiode, uitgezon­
derd een significante daling van de РаОг in de 10% Plmax groep. Significante 
correlaties werden gevonden tussen de verandering in spierkracht en spier-
duurvermogen en de verandering in nachtelijke saturatie. Onze conclusie is 
dan ook dat inspiratoire spiertraining de nachtelijke saturatie verbetert, onaf­
hankelijk van de saturatie overdag. 
De klinische consequentie van dit onderzoek is dat patiënten met een lichte 
nachtelijke hypoxie (gemiddelde NSaCte 85-90%) metTF-IMT behandeld kun-
nen worden. Tot op heden wordt niet geadviseerd om nachtelijke hypoxie, in 
afwezigheid van hypoxie overdag, te behandelen met zuurstof, omdat nog niet 
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bekend is wat de effecten zijn op de pulmonale hypertensie, het cor pulmonale 
en de overleving, terwijl dit wel een dure behandelingsvorm is. 
Algemene conclusie: 
Er bestaat een causale relatie tussen ademhalingsspierfunctie en nachtelijke 
saturatie bij deze groep COPD-patiënten. TF-IMT verbetert kracht en duurver-
mogen van deze spieren. Daarbij treedt ook een verbetering van de nachtelijke 
oxigenatie op. 
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Stellingen behorend bij het proefschrift 
Respiratory muscle function and nocturnal 
oxygenation in patients with 
chronic obstructive pulmonary disease 
Yvonne F. Heijdra 
Nijmegen, 12 december 1995 
1 De 'sniff' methode om maximale inspiratole spierkracht te meten biedt geen 
voordelen boven de statisch gemeten inspiratole spierkracht (Dit proefschrift) 
2 De maximale inspiratole transdiafragmale druk is bij patiënten met chronisch 
obstructieve longziekten in tegenstelling tot gezonden hoger in liggende dan in 
zittende houding (Dit proefschrift) 
3 De nachtelijke saturatie bij patiënten met chronisch obstructieve longziekten 
kan door behandeling met inspiratole spiertraining duidelijk worden verbeterd 
(Dit proefschrift) 
4 De klinische relevantie van de behandeling van alleen nachtelijke hypoxemie 
zal nog bewezen moeten worden 
5 Als de allergologie opgeheven wordt als zelfstandig specialisme zal dit niet 
ondergebracht moeten worden onder de inwendige geneeskunde zoals is 
voorgesteld door het Centraal College voor de erkenning en registratie van 
medisch specialisten, maar als aandachtsgebied bij de specialismen 
dermatologie, keel- neus- en oorheelkunde en longziekten 
6 De hersenstam van de primitieve beenvis 'Amia Calva' volgt grotendeels de 
functionele indeling in kolommen volgens Herrick en Johnston (YF Heijdra 
en R Nieuwenhuys, The Journal of Comparative Neurology 1994, 339 12-26) 
7 De sensitiviteit en specificiteit van de cytologische schildklierpunctie bij een 
koude nodus hangt sterk af van het eigen pathologisch-anatomisch 
laboratorium 
8 BIJ sollicitatie-procedures voor medisch specialisten wordt te veel waarde 
toegekend aan de doctors-titel 
9 De hoogte van het tennisnet zou aangepast moeten worden aan de toename 
van de gemiddelde lengte van de spelers om het evenwicht te herstellen 
tussen de service en het spel dat hierop volgt 
10 Gedeelde smart is halve smart (Onze proefschriften) 


